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ABSTRACT

GENOME VARIATION ACROSS CANCERS SCALES WITH TISSUE
STIFFNESS—AN INVASION-MUTATION MECHANISM

Charlotte Rose Pfeifer
Dennis E. Discher

Analysis of published cancer genome sequencing data reveals that cancers arising in
stiff tissues, such as lung and skin, exhibit more than 30-fold higher mutation rates than
those arising in soft tissues, like marrow and brain. This scaling relationship suggests a
possible mechanical source of cancerous mutations. We hypothesize that when cancer
cells squeeze through small holes in stiff fibrous tissues during tumorigenic invasion,
they sustain nuclear stress, leading to DNA damage and ultimately genomic variation.
Consistent with this hypothesis, we show that migration of diverse cancer cell lines
through constricting pores causes excess DNA damage as well as a transient delay in
cell cycle progression. We present evidence that the observed increase in DNA damage
could be due to partial depletion of DNA repair proteins throughout the nucleus,
which physically inhibits repair of routine DNA breaks. In particular, we describe
two ways in which constricted migration mis-localizes, and thus partially depletes,
mobile nuclear factors including DNA repair proteins: (1) curvature-driven nuclear
rupture, causing leakage of mobile factors from the nucleus into the cytoplasm; and
(2) phase separation of mobile nuclear factors from chromatin inside the constriction.
Altogether, this thesis presents biophysical studies that aim to shed light on an
intriguing scaling relationship from cancer genomics.
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1

Introduction

Many processes in vivo require cells to move through dense, three-dimensional tissue.
Cells migrate into wounds during healing (Clark et al. 1982) and into vessel-adjacent
matrix during angiogenesis (Lamalice et al. 2007). White blood cells squeeze through
capillaries of only 2-3 µm in diameter and extravasate into sites of tissue damage
or infection (Luster et al. 2005). Embryogenesis involves stem, progenitor, and
committed cells moving and positioning themselves in developing organs (Kurosaka
and Kashina 2008). Cancer cells invade healthy tissue, penetrate basement membrane
barriers, and enter distant capillary beds during metastasis (Liotta et al. 1991).
As the largest and stiffest organelle (Dahl et al. 2008), the nucleus has long been
speculated to sterically limit a cell’s ability to migrate through small, stiff pores
in tissue matrix (Lichtman 1970). Indeed, softening the nucleus by knockdown of
key nuclear structure components can enhance the rate of migration through small
constrictions (Harada et al. 2014; Shin et al. 2013), consistent with the idea of the
1
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nucleus as a physical impediment to migration.
We begin this chapter by describing the deformation of the nucleus during 3D
migration and also some of the components that determine the mechanical properties
of the nucleus, especially the lamins and the density of chromatin. Then, we consider
the impact of such large deformation on nuclear envelope structure, local chromatin
compaction, and a complex redistribution of mobile nuclear factors. Constricted
migration causes frequent lamina rupture (Chapter 4), which—along with ‘squeeze-out’
of mobile nuclear proteins (Chapter 5)—leads to mis-localization of crucial DNA
repair factors and an increase in DNA damage (Chapter 3). Finally, we discuss some
downstream consequences of constriction-induced DNA damage, particularly effects on
cell cycle progression (Chapter 3) and genome integrity (Chapter 2). This chapter will
thus introduce concepts of nuclear mechanics during cell migration, while outlining
some of the biophysical consequences of severe nuclear deformation.

1.1

Structure of the nucleus

Although nuclear sizes vary among and even within cell types, including cell cycle
effects, the nucleus is typically the largest cellular organelle with a diameter of ∼5 to
20 µm (Dahl et al. 2008). However, shape is context-dependent: for most stationary
cells in situ or grown in 3D scaffolds, the nucleus tends to be ellipsoidal, whereas
2D culture drives cell spreading and strong nuclear flattening (Khatau et al. 2009).
Forces generated by the cell’s gel-like cytoskeleton sculpt the nucleus in such contexts.
During constricted migration, the plasma membrane, cytoskeleton, and cytoplasm are
all readily deformed, with cytoplasmic protrusions squeezing into channels of even
2
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submicron diameter (Wolf et al. 2013). By contrast, the nucleus is ∼2- to 10-fold
stiffer than the surrounding cell body (Caille et al. 2002; Guilak et al. 2000), making
its constriction a more torturous—and rate-limiting (Davidson et al. 2015)—step
in the process of 3D migration.
The nuclear envelope, which defines the boundary of the nucleus, consists of two
closely apposed lipid bilayers: the inner nuclear membrane (INM) and the outer
nuclear membrane (ONM). Both are continuous with the endoplasmic reticulum. Just
below the INM is the nuclear lamina (Fig. 1.1), a dense meshwork of intermediate
filament proteins (lamins) that confers mechanical support and stiffness to the nuclear
envelope (Ungricht and Kutay 2017). Together, the envelope and lamina surround
the nucleoplasm, the genome (i.e. chromatin), and various subnuclear bodies—mostly
ribonucleic protein complexes like nucleoli, promyelocytic leukemia (PML) nuclear
bodies, Cajal bodies, and splicing speckles (Martins et al. 2012).
The nucleus mechanically couples to the cytoskeleton by way of Linker of Nucleoskeleton and Cytoskeleton (LINC) complexes (Irianto et al. 2016b). A LINC complex
consists of a SUN protein that binds to the lamina and connects via nuclear envelope
spectrin repeat proteins (nesprins) to a KASH domain on the ONM (Tapley and Starr
2013). The cytoplasmic region of the KASH domain then mediates interactions between
the nucleus and the cytoplasm/cytoskeleton by tethering the ONM to cytoskeletal
microtubules, actin filaments, and intermediate filaments (Tapley and Starr 2013).
Numerous experiments demonstrate this physical nucleo-cytoskeletal linkage: for
example, targeted laser ablation of the actin cytoskeleton causes the nucleus to move
laterally and away from the culture substrate, and can even cause local nuclear
3
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Figure 1
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Figure 1.1: A-type and B-type lamins form a dense meshwork on the inside of the
nuclear envelope. The nucleus mechanically couples to the cytoskeleton by way of Linker of
Nucleoskeleton and Cytoskeleton (LINC) complexes.

deformation (Mazumder and Shivashankar 2010; Nagayama et al. 2011). And the
disabling of endogenous LINC complexes results in loss of cellular mechanical stiffness
comparable to the loss of stiffness observed with lamina disruption (Stewart-Hutchinson
et al. 2008). Because the nucleus mechanically couples to the cytoskeleton—and
ultimately, via adhesions, to extracellular matrix (ECM)—it deforms with the cell
during 3D migration (Broers et al. 2004; Swift et al. 2013).

1.2

Deformation of the nucleus during constricted
migration

Different cell types employ different single-cell migration modes in 3D environments.
Tissue fibroblasts exhibit relatively slow (∼0.5-1 µm/minute) mesenchymal cell
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migration (Cukierman et al. 2001), while dendritic cells and immune cells (e.g.
leukocytes) favor ∼10-to-40-fold faster amoeboid movement (Friedl et al. 1998).
Mesenchymal cell migration proceeds as follows: (1) the cell polarizes to create
a leading edge that extends actin-rich protrusions; (2) the protrusions form adhesions
to ECM contacts; (3) myosin II-mediated contraction of the actin cytoskeleton shortens
the rear of the cell and advances the cell body; and (4) the trailing edge detaches
from the substratum, allowing the cell to translate forward. Such migration can
include degradation of the ECM by matrix metalloproteinases (MMPs) (Even-Ram
and Yamada 2005). By contrast, amoeboid migration is typically non-proteolytic, and
it involves weaker, more transient adhesive interactions with the ECM (Parri and
Chiarugi 2010). In reality, migration modes exist along a continuum, and the mode
adopted by a given cell in a given microenvironment seems to be determined by factors
such as ECM stiffness and the intrinsic contractility of the cell (Parsons et al. 2010).
Regardless of the particular motility mode, deformation of the cell during 3D
migration leads to deformation of the nucleus. The first step in the migration
process, polarization, requires the cell’s cytoskeleton and organelles—including the
nucleus—to rearrange themselves within the cell body. In polarized mesenchymal cells,
fibroblasts, neurons, and most cancer cells, the nucleus assumes a rearward position,
thus establishing a leading edge-to-centrosome-to-nucleus axis along the direction of
locomotion—at least on rigid substrates (Barnhart et al. 2010; Gasser and Hatten 1990;
Gomes et al. 2005; Tsai and Gleeson 2005). On soft substrates, the centrosome is more
random in location (Raab et al. 2012). Whereas most nuclear movements are thought
to be microtubule-mediated (Luxton et al. 2010), nuclear repositioning for migration
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is driven by retrograde flow of actin: inhibiting myosin-II or actin with blebbistatin
or cytochalasin D, respectively, is known to block actin retrograde flow, and doing
so prevents rearward nuclear movement during cell polarization (Gomes et al. 2005),
although cells can still migrate with myosin-II inhibition in 2D. Actin cables are
coupled to the dorsal surface of the nuclear envelope by LINC complexes, as described
above; these linkages transmit force from actin flow to the nucleus (Luxton et al. 2010).
After polarization, as the cell proceeds to squeeze into a tight constriction in 3D,
the nucleus moves with the cell body by being either pushed or pulled. Under the
pushing mechanism, the nucleus is squeezed forward by actomyosin contraction in the
(detached) rear of the cell (Roth et al. 1995; Zhang et al. 2007). Such trailing-edge
contraction propels nuclear translocation during constricted migration of leukocytes:
myosin-II-inhibited leukocytes migrating through 3D gels exhibit a peculiar elongated
shape with a rounded back due to nuclear immobilization at the rear ends of the cells.
Because posterior actomyosin contraction is required to retract and detach the cell
membrane, myosin-II inhibition renders leukocytes unable to push their large, rigid
nuclei through small interstices in the gel (Lammermann et al. 2008). Similarly, in
3D migration studies of breast, brain, and other cancer cells, non-muscle myosin-II
localizes to the perinuclear cytoskeleton and cell posterior, and then exerts pushing
forces to advance the nucleus (Beadle et al. 2008; Harada et al. 2014; Ivkovic et al.
2012). Knockdown of myosin-IIB dramatically slows migration of breast cancer cells
through narrow channels, whereas knockdown of myosin-IIA—the non-muscle myosinII isoform that generates force during leading-edge protrusion—has little effect on
migration time through the constrictions. The isoforms have almost opposite effects
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in 3D migration of glioma cells. Nesprin-2 provides a possible physical link between
the nucleus and myosin-IIB-mediated force generation (Beadle et al. 2008).
Under the pulling mechanism, actomyosin contraction physically pulls the nucleus
forward during 3D migration. When Rac1 photoactivation is used to create a new
leading protrusion in a crawling fibroblast (by triggering local F-actin polymerization
at the front of the cell), the nucleus moves persistently toward the new leading
edge without trailing-edge detachment—even when microtubules are depolymerized
(Wu et al. 2014). In lobopodial fibroblasts, the pulling forces are generated by
non-muscle myosin-IIA-containing actomyosin bundles that form complexes with
the intermediate filament protein vimentin and the LINC protein nesprin-3 (Petrie
et al. 2014). Ultimately, it is likely that both pushing and pulling forces contribute—
in a cell type- and migration mode-dependent manner—to the forward motion of
nuclei during 3D migration.
Whether the nucleus is pushed or pulled by actomyosin, it can undergo huge
deformation when constricted. Whereas the nucleus maintains its original ellipsoid
shape and simply re-orients during transit through large pores in loose tissues (Friedl
et al. 2011), it is severely locally compressed by small pores in dense tissues, resulting
in transient shape changes (Harada et al. 2014). Reflecting the larger deformation
required by smaller pores, migration speed decreases linearly with decreasing pore
size (Irianto et al. 2017). Compression of the nucleus during migration is actuated
by cytoskeletal forces and opposed by the geometry of ECM pores. In 2D culture on
stiff glass substrates, a dome-like perinuclear actin cap largely aligns with the overall
cell orientation (Khatau et al. 2009), and this cap might actively drive nuclear shape
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changes during 3D migration. Moreover, intermediate filaments including vimentin
surround the nucleus in a fibrous “cage” that is required for nuclear re-shaping in
response to actomyosin-induced forces (Neelam et al. 2015). Both the actin cap
and cage-like intermediate filaments connect to the nuclear envelope through LINC
complexes; hence, LINC complex disruption impairs nucleo-cytoskeletal-mediated
nuclear deformation and often causes migratory defects (Khatau et al. 2012).
Beyond single-cell migration, it should be noted that cells often maintain their
cell-cell junctions and undergo collective migration, traveling in sheets, strands, tubes,
or clusters (Parri and Chiarugi 2010). Such movement usually occurs along smooth
ECM interfaces (Friedl et al. 2011); for example, collective migration of invasive
cancer cells through tissue barriers requires MMPs to clear tracks—devoid of sterically
impeding fibers—in the ECM. Multicellular invasion along these proteolytic tracks
causes significantly less morphological adaptation and nuclear deformation than does
single-cell migration through non-reorganized collagen (Wolf et al. 2007). Thus, the
severity of nuclear deformation depends on the mode of migration—collective versus
single-cell, proteolytic versus non-proteolytic.

1.3

Regulators of nuclear deformability

Nuclei have viscoelastic properties (Dahl et al. 2005; Guilak et al. 2000), meaning that
they exhibit stress relaxation: when a constant deformation is applied, the resulting
mechanical stress on the nucleus decays over time. They also exhibit a creep response
such that when a constant stress is applied, the nucleus continues permanently to
deform. Viscoelastic materials are often modeled as a network of elastic springs and
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viscous dashpots. For example, in the three-component standard linear solid model,
which is designed to show exponential stress relaxation and exponential creep, a spring
is placed in parallel with a “Maxwell arm” consisting of a spring and dashpot in series
(Meidav 1964). This model has been applied to isolated articular chondrocyte nuclei
pulled by constant suction pressure into micropipettes (Guilak et al. 2000). However,
spring-dashpot models are limited in the case of nuclei because nuclear stress relaxation
and creep occur over many decades of time. To accurately model viscoelastic behavior
on such timescales would require a very large (physically meaningless) number of
spring and dashpot elements, which could increase mathematical complexity to the
point of impracticality (Lange and Fabry 2013).
As opposed to a superposition of very many exponential response functions, a
power-law model arguably provides a simpler and more physically meaningful approach
to describe nuclear mechanics under deformation. Indeed, micropipette aspiration
and atomic force microscopy (AFM) assays indicate that isolated intestinal epithelial
cell nuclei exhibit power-law rheology (Dahl et al. 2005). The creep compliance J(t)
of the nucleus—that is, the ratio of nuclear strain to applied stress as a function
of time t—is given by


J(t) = J0

t
sec

α

[=]

1
,
kP a

(1.1)

where the prefactor J0 corresponds to the inverse of the dynamic shear modulus
G measured at a frequency of 1 rad/s (Dahl et al. 2005; Hildebrandt 1969; Lange
and Fabry 2013). The exponent α depends on the dynamics of the force-bearing
elastic structures of the nucleus (Lange and Fabry 2013)—in particular, the lamina
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and the chromatin, as we will describe below. A purely elastic solid would have a
power-law exponent of α = 0, while a purely viscous fluid would have an exponent
of α = 1. The measured value for isolated nuclei from intestinal epithelial cells
is α ≈ 0.2-0.3 (Dahl et al. 2005).
Power-law rheology could have a number of important consequences for nuclei
undergoing constricted migration. First, in a material with a power-law exponent
of α ≈ 0.2-0.3, mechanical stresses decay slower than exponentially, but they do
become small for large enough t. To illustrate, if the effective stiffness of a nucleus
is 1 kPa when measured at a frequency of 1 Hz, then the same nucleus should have
an effective stiffness of only ∼0.3 kPa when measured at 0.01 Hz. Thus, ignoring
active mechanics, as the speed of nuclear movement decreases, so do the movementresisting forces that arise from nuclear deformation (Lange and Fabry 2013). Second,
the power-law behavior of nuclei has implications for chromatin organization during
migration. Other systems with power-law rheology, such as microgels, have an
essentially infinite number of intermediate conformations corresponding to infinite
relaxation modes or timescales. It seems likely that nuclear components at different
length scales—from nucleosomes to chromosomes to chromatin fibers—also have
intermediate conformations of mechanical relaxation, reflecting metastable states that
could impact gene expression kinetics (Dahl et al. 2005).
The power-law viscoelasticity of nuclei is determined principally by the lamina and
chromatin—or at least the chromatin volume fraction. We will discuss each structure in
turn. The intermediate filaments that comprise the nuclear lamina are divided into two
sub-types (Fig. 1.1): A-type lamins (lamin-A and -C), which are alternative splicing
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products of the LMNA gene; and B-type lamins (lamin-B), which are encoded by the
LMNB1 and LMNB2 genes. Although A- and B-type lamins have similar amino acid
sequences and structural features, they have different post-translational modifications
(Irianto et al. 2016b): the lamin-B monomer is permanently modified by addition of a
farnesyl group, which is hydrophobic and tethers lamin-B to the INM (Hennekes and
Nigg 1994). As a result, lamin-B is less mobile and dynamic than mature lamin-A
(Shimi et al. 2008), from which the farnesylated C-terminus is cleaved (Irianto et al.
2016b). Like other intermediate filament proteins, including keratin and vimentin,
lamin monomers form coiled-coil parallel dimers that assemble into filaments of ∼3.5
nm thickness, organized in complex meshworks of ∼14 nm thickness (Herrmann et al.
2009; Turgay et al. 2017). Cryo-electron tomography of mouse embryonic fibroblasts
suggests that both lamin sub-types are present throughout the meshwork, including
in densely packed and sparsely occupied regions (Turgay et al. 2017).
Lamin-A levels vary widely across adult cell types, scaling with resident tissue
stiffness (Swift et al. 2013). Meanwhile, lamin-B expression remains relatively constant
such that the ratio of lamin-A to -B is highest in stiff tissues like muscle and bone,
and lowest in soft tissues like brain and fat. The positive scaling of lamin-A:B ratio
with tissue microelasticity suggests a possible role for lamin-A in protecting the
nucleus against mechanical stresses, which are expected to be higher in stiffer tissues.
Consistent with such a protective function, it has been speculated that lamin-A
confers viscous stiffness to nuclei, while lamin-B contributes to nuclear elasticity.
When nuclei of diverse tissue lineage are pulled into micropipettes under controlled
pressure (∼kPa), each nucleus extends within seconds in a viscoelastic manner, as
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described above. Importantly, effective nuclear viscosity increases more rapidly than
effective elasticity as a function of lamin-A:B stoichiometry. This trend suggests that
whereas lamin-B functions like the elastic walls of a balloon, restoring the nucleus
to its original shape in response to applied stresses, lamin-A acts like a viscous fluid
that fills the balloon and resists deformation (Swift et al. 2013). Moreover, lamin-A
knockdown is known to soften nuclei (Harada et al. 2014; Pajerowski et al. 2007),
and mutations in lamin-A are associated with diseases—“laminopathies” including
muscular dystrophy and premature aging—in which nuclei are unusually soft and
fragile (Sullivan et al. 1999). Levels of lamin-A and lamin-B are abnormal in many
cancers; lamin-A is low in lung and breast tumors, for example (Irianto et al. 2016b).
As a crucial mechanical component of the nucleus, the lamina regulates nuclear
deformability during constricted migration. Lamin-A in particular is known to be
rate-limiting in 3D migration of diverse human cell lines, ranging from brain and lung
cancer cells to primary mesenchymal stem cells (MSCs) (Harada et al. 2014). For
a given cell type, wild-type levels of lamin-A protect against stress-induced death
during transit through small pores, whereas low levels cause susceptibility to stress
and apoptosis, and high levels impede migration. Thus, lamin-A is a barrier to 3D
migration, but it promotes nuclear integrity and survival (Harada et al. 2014).
Chromatin also plays some role in the mechanical response of the nucleus. Like
any polymer, chromatin can be dilute and swollen by surrounding mobile solvent
or else condensed and devoid of solvent—with densely packed polymer expected to
be stiffer. Divalent cations such as Ca2+ and Mg2+ condense chromatin and indeed
result in smaller and stiffer nuclei (Dahl et al. 2005). Local chromatin density is
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typically non-uniform and defines chromatin’s structural and functional state: DNA
wrapped around histone octamers is either (i) loosely packed ‘euchromatin’ with
actively transcribed genes, or (ii) dense ‘heterochromatin’ with repressed transcription
(Dahl et al. 2008). The relative deformability of euchromatin structures hints that
external forces—like those imposed by constricting pores during 3D migration—could
easily reorganize gene-rich regions of the genome (Pajerowski et al. 2007).
Isolated chromosomes respond elastically to applied stress (Cui and Bustamante
2000; Marko 2008), whereas chromatin within the nucleus (including surrounding
nucleoplasm) responds by either flowing with the stress or sustaining the stress.
Tethering of chromatin by specific factors to the INM (Fig. 1.1) seems to constrain
flow and favor elastic responses to small forces in yeast nuclei that lack a nuclear
lamina, and untethering the chromatin from the INM allows the chromatin to flow
under deformation to a new, lower-energy configuration (Schreiner et al. 2015). Nuclear
stretching experiments likewise show that chromatin can confer some elastic resistance
to small nuclear deformations (Stephens et al. 2017), although nuclear volume changes
can affect this result. Moreover, micropipette aspiration experiments indicate that
chromatin flows and locally condenses in the pipette like a polymer from which
solvent is locally squeezed (Pajerowski et al. 2007). Chromatin can thus contribute
to nuclear mechanical properties and influence the extent or rate at which a nucleus
deforms into a constriction.
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1.4

Effect of nuclear deformation on chromatin
and nuclear factors

Migration through constricting pores is expected to (i) impose curvature on membraneattached filaments of lamin-B that do not tolerate large bending (Xia et al. 2019)
and (ii) exert compressive forces that locally squeeze out nucleoplasm. As we will
describe in Chapter 4, high-curvature regions tend to show dilution of lamin-B in
constricting pores as well as in micropipette aspiration. At the leading tip of the
nucleus, dilution can produce a hole in the lamina—especially if lamin-A does not
quickly flow and fill the hole. Hole formation should lead to local nucleoplasm outflow
and, if the nucleoplasm is pressurized, local inflation of the nuclear envelope as a ‘bleb’
that can burst to cause leakage of nuclear factors and even herniation of chromatin
into the cytoplasm (Fig. 1.2, Deviri et al. (2017)). Blebs after constricted migration
had already been seen to lack lamin-B but enrich for lamin-A (Harada et al. 2014),
and migration of various cancer cell lines, immortalized epithelial cells, and primary
dendritic cells through narrow channels subsequently confirmed nuclear envelope
rupture (Denais et al. 2016; Raab et al. 2016).
Rupture, which can occur even without bleb formation (Pfeifer et al. 2018;
Xia et al. 2018), generally leads to exchange of nucleo-cytoplasmic contents, as
indicated by cytoplasmic accumulation of GFP-NLS (nuclear localization signal) and
nuclear accumulation of mCherry-cGAS, a normally cytoplasmic DNA binding protein.
Whereas lamina ruptures seem sustained for many hours, resealing of nuclear envelope
lesions is mediated within minutes. Components of ESCRT III (endosomal sorting
complex required for transport III) had been reported as key (Denais et al. 2016;
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Lamin-B
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DNA
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Figure 1.2: Constricted migration disrupts the lamina and leads to nuclear bleb formation.
Cartoon: Constricting pores impose curvature on the nuclear membrane, which causes
dilution of membrane-attached lamin-B filaments that do not tolerate large bending. Dilution
can produce a hole in the lamin-B, leading to nucleoplasm outflow that locally inflates the
nuclear envelope and generates a bleb. The bleb can then burst to cause leakage of nuclear
factors into the cytoplasm, with corresponding leakage of cytoplasmic factors into the nucleus.
Images: A gallery of nuclear blebs and blebless scars (yellow arrows) in bone cancer cells
that have migrated through rigid 3 µm pores. Both blebs and scars are characteristically
enriched in lamin-A but deficient in lamin-B. A majority of blebs/scars form in regions of
high Gaussian curvature, like at the pole of an elongated nucleus.
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Raab et al. 2016), but further studies concluded ESCRT III is not required to repair
ruptures, and instead repair of nuclear ruptures reportedly requires other factors
such as a cytoplasmic fraction of (non-phosphorylated) barrier-to-autointegration
factor (BAF) that quickly localizes to a ruptured site (Halfmann et al. 2019). Further
study is needed to resolve whether ESCRT III, BAF, or other components have
roles in nuclear rupture repair. It is possible that the specific repair machinery
depends on context and/or cell type.
Chapter 3 will show that nuclear rupture is accompanied by excess DNA damage
based on increased foci of the damage marker γH2AX and increased foci of the
upstream kinase phospho-ATM. Pore migration studies have also provided supporting
evidence of constriction-induced DNA damage in terms of single-cell electrophoresis
of DNA (“comet assays”)(Irianto et al. 2017). While it is tempting to propose that
chromatin fragmentation as a nucleus enters and elongates in a small pore might
account for the increased damage, this mechanism seems unlikely given that stretched
chromatin maintains its integrity. In living cells, an mCherry-tagged nuclease was
targeted to a submicron locus on chromosome 1, where it causes DNA cleavage—
and thus recruitment of DNA repair factors to a large region around the locus.
Micropipette aspiration of these cells and their nuclei shows that the chromatin
aligns and stretches parallel to the pore axis. Importantly, even though DNA within
the engineered locus is cleaved by nuclease, intensity profiles of mCherry indicate
continuity, meaning that integrity of the chromatin is maintained during nuclear
distention (Irianto et al. 2016d). Chromatin shearing is therefore unlikely to explain
the excess DNA damage that follows pore migration.
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Another possible mechanism is global inhibition of DNA repair. DNA breaks
constantly form by various means, including replication or oxidative stress, and are
repaired by dedicated factors that are often implicated in cancer (including ATM,
BRCA1, etc.). Damage rate and repair rate reach a steady state dependent on the
level or activity of the repair factors. Roughly,
Net DNA Damage = Damage Sources / Repair Factors.

(1.2)

The hypothesis goes that constriction-induced nuclear rupture mis-localizes crucial
DNA repair proteins from the nucleus into the cytoplasm. Such mis-localization causes
partial depletion of repair factors throughout the nucleus, which physically inhibits
repair of routine DNA breaks and leads to the observed transient increases in DNA
damage (Irianto et al. 2017; Pfeifer et al. 2018). Inactivating mutations in DNA
repair factors BRCA1 and BRCA2 are such well-established risk factors for cancer
that they warrant surgical removal of ovary and breasts (Levy-Lahad and Friedman
2007). Mouse knockouts or heterozygous mutants for BRCA1 and BRCA2, among
other repair proteins, have indeed been shown to alter chromosome copy numbers
(Holstege et al. 2010). Therefore, any migration-induced physical depletion of such
factors should also increase DNA damage and mutation probabilities.
Surprisingly, constriction can also mis-localize any mobile nuclear factor completely
independent of nuclear envelope rupture: as Chapter 5 will show, constrictions
“squeeze out” all diffusible proteins from regions of high DNA compaction, such as at
the entrance of a constricting pore. Repair factors such as BRCA1, KU80, or 53BP1
are ordinarily mobile and diffuse in the nucleus (Bekker-Jensen et al. 2005; Pryde
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et al. 2005). However, during micropore migration, mobile proteins are significantly
depleted within the constriction in contrast to DNA or chromatin-bound proteins
(e.g. histone H2B), which are instead enriched in the constriction. This nuclear
factor segregation is also observed during micropipette aspiration: all of a dozen
mobile proteins examined—including upstream DNA damage response factors (e.g.
MRE11, RPA) as well as downstream factors (e.g. BRCA1)—segregate away from
chromatin (Irianto et al. 2016a). In Chapter 5, we will present a simple elastic-fluid
model of the nucleus that provides insight into why protein squeeze-out occurs and
gives a mechanistic basis for the hypothesis that severe constriction can inhibit DNA
damage repair. Briefly, if chromatin is modeled as a solid mesh of volume fraction f
(f ∼ 67% of the nuclear volume in 2D culture (Bancaud et al. 2009)), then the free
volume for diffusion of mobile factors is (1 - f ) ∼ 33% (Bennett et al. 2017). However,
constriction increases the local density of chromatin by a factor of ∼1.25 such that
inside the pore fconstricted ∼ 84%, which causes the free volume there to decrease to
(1 - fconstricted ) ∼ 16%. The 50% decrease in free volume agrees with experiments
(Bennett et al. 2017; Irianto et al. 2016a) and implies that a rupture-independent
mechanism of repair factor mis-localization can impede the DNA damage response,
contributing to excess DNA damage after constricted migration.

1.5

Downstream consequences of constriction-induced
nuclear deformation

Excess DNA damage is known to have many possible effects, including a cell cycle
block (Dasika et al. 1999) or mis-repair leading to genomic variation. Evidence of
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the latter has been obtained with clonal bone cancer cells that were subjected to
three consecutive migrations through constricting pores. From among these thricemigrated cells, the genomes of six single-cell-derived clones were quantified by singlenucleotide polymorphism (SNP) array analysis. Compared to the pre-migration
clone, the migrated clones showed unique chromosome copy number changes and
loss of heterozygosity (Irianto et al. 2017). Because the pre-migration population
was 100% clonal and the migrated sub-clones exhibited unique genomic changes,
it stands to reason that migration can cause—as opposed to merely select for—
genomic variation. Nevertheless, rare cells might be selected by the migration,
which motivates further study.
The clinical implications of constricted migration causing heritable mutations are
vast. Advances in whole-genome sequencing technology have allowed for complete
cataloguing of the genomic changes that occur in cancers of different types (Martin
et al. 2015; Matsushita et al. 2016; Schumacher and Schreiber 2015). In a metaanalysis of published cancer sequencing data, which we will describe in Chapter 2,
the somatic mutation rates for 36 cancer types were culled from a number of recent
papers (Alexandrov et al. 2013; Chen et al. 2014; Lawrence et al. 2013; Martincorena
and Campbell 2015; Martincorena et al. 2015; Schumacher and Schreiber 2015; Shain
et al. 2015), as were the stiffnesses of the healthy tissues in which those cancers arise.
This meta-analysis revealed that cancers arising in stiff tissues, such as lung and skin,
exhibit more than 30-fold higher somatic mutation rates than those arising in soft
tissues, like marrow and brain. Although tumors often stiffen—or, less frequently,
soften—their surrounding tissue over the course of tumorigenesis (Levental et al. 2010),
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the stiffness of a typical brain tumor microenvironment never reaches that of a typical
bone tumor microenvironment, so the stiffness gradient among tissue types prevails.
The scaling of genomic variation with tissue stiffness suggests a possible mechanical
source of cancerous mutations. One promising hypothesis implicates constricted
migration of cells through stiff tissues. Tissue stiffness increases with abundance of
fibrous protein (e.g. collagen) (Swift et al. 2013), and denser collagen matrix has
smaller interstitial pores (Yang et al. 2009). Therefore, when cancer cells invade
normal tissue during tumor growth (Liotta et al. 1991), they generally encounter a
higher collagen concentration and smaller pores in stiffer tissues than in softer ones. As
discussed in this chapter, squeezing through small pores—but not larger ones—severely
deforms the nuclei of invading cancer cells, which stresses the nuclear lamina and
causes DNA damage, heritable genome changes, and even cell death (Harada et al.
2014; Irianto et al. 2017). Thus, constricted migration through increasingly small
holes in increasingly collagen-rich matrix stands as a possible explanation for the
relation between mutation rate and tissue stiffness.
In addition to threatening genome integrity, constriction-induced DNA damage
might also cause cell cycle defects. In Chapter 3, standard cell proliferation assays
show that migration through 3 µm pores—but not 8 µm pores—indeed causes a
transient delay in cell cycle for diverse cancer cell lines (Pfeifer et al. 2018). These
findings are relevant to the so-called “go-or-grow” hypothesis, long-debated in cancer
research, which holds that proliferation and migration are mutually exclusive events
(Garay et al. 2013; Giese et al. 1996). The surprising delay in growth has implications
for the invasive migration of cancer cells away from a physically crowded tumor mass
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Figure 3
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Contactinhibited
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Figure 1.3: Invasion and proliferation are hallmarks of cancer. Invading cancer cells
squeeze into regions of low cancer cell density, including nearby tissues or blood capillaries.
The resulting loss of contact inhibition could in principle encourage proliferation. However,
migration through 3 µm pores causes a transient delay in cell cycle for diverse cancer cell
lines, illustrating a “go, damage, and then grow” process.

and into nearby stiff tissues or blood capillaries (Fig. 1.3). Moreover, combined
proliferation/migration assays also show that G1- and G2-phase cells incur a similar
excess of DNA damage, suggesting that constriction-induced DNA damage occurs
independent of cell cycle phase and hence independent of DNA replication (Pfeifer
et al. 2018). Rescue of the excess DNA damage was partially achieved in recent studies
by co-overexpression of multiple DNA repair factors and also by antioxidant inhibition
of break formation, but the apparent block in cell cycle was unaffected (Xia et al.
2019). Combined treatment—with repair factors and antioxidant simultaneously—
completely rescued cell cycle suppression by DNA damage, revealing a sigmoidal
dependence of cell cycle on excess DNA damage.
Downstream consequences of constriction-induced nuclear deformation emerge in
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non-cancer contexts, as well. Stem and progenitor cells such as myoblasts and human
MSCs exhibit similar damage and cell cycle delay after constricted migration (Smith
et al. 2019). Furthermore, fewer myoblasts are able to fuse into regenerating muscle
in vivo after in vitro constricted migration, and myo-differentiation in vitro is likewise
suppressed. Human MSC differentiation (e.g. osteogenesis) is also affected compared
to non-migrated cells, but, in contrast to myogenesis, osteogenic differentiation is
found to be increased by constricted migration. This finding could be relevant to
bone formation in vivo, where MSCs and osteoblasts likely squeeze through rigid
porous bone. Differentiation-related factors including transcription factors (MYOD
and KU80 (Smith et al. 2019), YAP1 (Xia et al. 2019)) mis-localize to cytoplasm, so
differentiation effects of constricted migration could have multiple causes.

1.6

Conclusion and outline

Cells in vivo squeeze through 3D tissues during a variety of physiological processes,
ranging from morphogenetic development and wound healing to cancer invasion.
Because the nucleus mechanically couples to the cytoskeleton, it deforms with the
cell during such 3D migration. The severity of nuclear deformation depends on
the mechanical properties of the nucleus, which are determined principally by the
lamina but also the chromatin, especially in the case of high volume fraction. As
described in this chapter, constriction-induced deformation can cause nuclear envelope
rupture, chromatin remodeling including local changes in chromatin density, and mislocalization of diffusible nuclear factors. These effects are accompanied by excess DNA
22

1. Introduction
damage, which yields a number of downstream consequences, notably documented
delays in cell proliferation and differentiation.
The exact mechanism(s) by which constricted migration leads to excess DNA
damage remains an active topic of research. Some in the field have speculated that
cytoplasmic nucleases might enter a ruptured nucleus and cause damage (Denais et al.
2016; Raab et al. 2016). However, the fact that migration-induced DNA breaks are
pan-nucleoplasmic (Irianto et al. 2017), rather than concentrated at the rupture site as
one would expect for nuclease entry, suggests a more global damage mechanism. Along
these lines, global loss of DNA repair proteins due to rupture-induced mis-localization
of mobile nuclear factors stands as an alternative mechanism, which was introduced in
this chapter and will be advanced throughout this thesis. Rescue experiments—in which
possible damage mechanisms are systematically disabled/counteracted in an attempt
to reduce or even eliminate excess damage after migration—should provide insight into
the cause of constriction-induced DNA breaks. One such study has already indicated
that co-overexpression of multiple DNA repair proteins during migration partially
rescues the excess damage as does anti-oxidant, with the combination providing a full
rescue of both DNA damage and cell cycle suppression (Xia et al. 2019). More such
studies are needed to resolve outstanding questions of mechanism(s).
Now that we have introduced concepts of nuclear mechanics during cell migration
and outlined some of the biophysical consequences of severe nuclear deformation,
this thesis will proceed as follows: in Chapter 2, we will present evidence from
cancer genome sequencing studies to demonstrate that cancers arising in stiff tissues
exhibit many-fold more mutations than those arising in soft tissues. We will discuss
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possible mechanical sources of cancerous mutations that might help explain this
scaling of genomic variation with tissue stiffness. In particular, we will focus on an
invasion-mutation hypothesis, which holds that genomic variation is due to DNA
damage sustained by cancer cells during tumorigenic invasion into small holes in
stiff tissues. Consistent with this hypothesis, Chapter 3 will show that migration
through constricting micropores causes excess DNA damage, as indicated by focal
accumulations of endogenous damage markers and by a damage-induced cell cycle
delay. We will argue that the observed increase in DNA damage might be caused
by partial depletion of DNA repair proteins throughout the nucleus, which could
physically inhibit repair of routine DNA breaks. In Chapters 4 and 5, we will describe
two ways in which constricted migration mis-localizes, and thus partially depletes,
mobile nuclear factors including DNA repair proteins: (1) nuclear envelope rupture,
causing leakage of mobile factors from the nucleus into the cytoplasm; and (2) squeezeout of mobile nuclear factors from the constriction. Altogether, this thesis presents
biophysical studies that aim to shed light on an intriguing scaling relationship from
cancer genomics, which will be fully elaborated in the next chapter.
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2

Genome variation across cancers scales
with tissue stiffness

Many different types of soft and solid tumors have now been sequenced, and metaanalyses suggest that genomic variation across tumors scales with the stiffness of
the tumors’ tissues of origin. This chapter is based on a review of current genomics
data, and it considers multiple ‘mechanogenomics’ mechanisms to potentially explain
this scaling of mutation rate with tissue stiffness. Since stiff solid tissues have higher
density of fibrous collagen matrix, which should decrease tissue porosity, invasion of
cancer cells into stiff tissues could squeeze the nucleus sufficiently to enhance DNA
damage. Diversification of a cancer genome after constricted migration is now clear.
Understanding how genome changes arise is important for cancer prevention and for
the development of cancer therapies including immunotherapies.
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2.1

Introduction

Tumors are often palpably stiffer than nearby normal tissue (Levental et al. 2010),
with stiffness of breast and liver, among other organs, correlating with cancer risk
(Boyd et al. 2007; Singh et al. 2014). Tissue stiffness likely contributes in normal cells
to motility (Pelham and Wang 1997) and differentiation (Engler et al. 2006), and
in cancer cells to invasion (Przybyla et al. 2016) and various epigenetic mechanisms
(Spencer et al. 2007), including stiffness-dependent nuclear localization of oncogenic
factors (e.g. YAP) (Dupont et al. 2011). It is unclear, however, if a physical attribute
of the microenvironment such as stiffness could contribute—in a ‘mechanogenomics’
type of process—to any of the many genetic changes that typically occur in cancer.
Meta-analyses of recently published cancer mutation data are presented in this
chapter, and the trends begin to suggest that—beyond some initial driver mutation(s)—
the large genomic variation across diverse cancers scales with tissue stiffness. Stiffnessdependent cell biological mechanisms for genome variation are needed to substantiate
any such correlation, and some molecular mechanisms are now emerging. In this thesis,
we focus on one possible mechanism based on the fact that stiffer tissues, including
tumors, are enriched in collagen (Swift et al. 2013), and many studies of collagen
gels show that denser collagen has smaller matrix pores (Yang et al. 2009). Thus,
as cancer cells invasively migrate into stiff, small-pore surroundings, the nucleus is
damaged, which might ultimately contribute to genomic diversity.
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frequently, soften—in tumorigenesis (Levental et al. 2010). The hierarchy of normal
tissue stiffness is therefore likely to prevail in cancer: that is, brain is softer than
liver, which is softer then bone, etc.—whether cancerous or not.
Childhood muscle and bone cancers have only slightly elevated somatic mutation
rates as compared to childhood marrow and brain cancers (Fig. 2.1), but they have
>10-fold more chromosome copy number changes and structural variants (Chen et al.
2014) (Fig. 2.2). This disparity suggests that large-scale, chromosome-level changes—
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Figure 2.3: (A) Melanomas from patients of ≤60 years have fewer copy number changes
than melanomas from patients over 60. The younger patients also have softer, less fibrotic
skin, as inferred from their lower average solar elastosis score; solar elastosis is the thickening
of skin due to prolonged sun exposure. (B) In skin cancer genomes, chromosome copy
number changes increase strongly with somatic mutation rate and lesion stiffness, with all
highest in “invasive melanoma.”

more so than somatic mutations—are signatures of some mutational process that
associates with tissue stiffness. In adult melanoma, fibrotic skin tends to be stiffer
and exhibit more chromosome copy number changes than softer, less fibrotic skin
(Diridollou et al. 2001; Shain et al. 2015) (Fig. 2.3A). Moreover, these copy number
changes increase even faster with stiffness than do somatic mutation rates, and all
mutations are most abundant in invasive melanoma (Shain et al. 2015) (Fig. 2.3B).
The relationship between chromosome-level mutations and stiffness thus holds even
within a given tissue type, hinting at a correlation between mutations and stiffness
that cannot be entirely explained away by exposure to carcinogens.
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2.3

Mechanical causes of mutation in the correlation of genomic variation with tissue stiffness

Scaling of genomic variation with tissue stiffness could result from at least three
possible mechanical sources of mutations. First, stiff matrix enhances cell proliferation,
as has been shown by an increase in BrdU incorporation with substrate stiffness in 2D
cultures of normal human smooth muscle and breast epithelial cells as well as mouse
embryonic fibroblasts (Klein et al. 2009). DNA replication in each cell division cycle
carries with it some risk of spontaneous mutation (Lawrence et al. 2013; Seshadri
et al. 1987), accounting for about 67% of mutations in human cancers (Tomasetti
et al. 2017). Since these mutations accumulate over successive generations, more
proliferation should mean more changes to the genome. This idea will be discussed
more thoroughly below in Section 2.4 and again in Chapter 3.
A second conceivable explanation for the scaling relationship is that stiffness
increases the frequency of nuclear envelope rupture (Tamiello et al. 2013). Such
rupture causes transient leakage into the nucleus of cytoplasmic factors, including
perhaps nucleases, that might damage DNA and contribute to genome instability
(Maciejowski et al. 2015). However, the increase of rupture frequency with substrate
stiffness has been observed only in cells with defects in lamin-A, which, as described
in Chapter 1, is one of the three intermediate filament proteins that confer strength
and stability to the nucleus. Yet, cancer types vary widely in their lamin-A expression
levels: it is downregulated in leukemia as well as in breast and lung cancers, whereas
it is upregulated in colorectal and skin cancers (for review: Irianto et al. (2016b)).
Lamin-A is highly mutated in multiple laminopathies, but cancer risk is not reported
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Many cell types

through stiff tissues, given that invasion is a ‘hallmark’ of cancer. Tissue
withstiffness
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increases with fibrous protein (e.g. collagen) concentration (Swift et al. 2013), which,
in turn, anti-correlates with extracellular matrix pore size (Yang et al. 2009) (Fig.
for viability,
growth, immune
invasion,etetc.
2.4). Hence, cancer cells invadingSELECTION
normal tissue,
as during
tumorcompatibility,
growth (Liotta
al.

1991), encounter higher collagen matrix levels and smaller pores in stiffer tissues than
in softer ones (Irianto et al. 2016c). Squeezing through small pores—but not larger
ones—greatly deforms the nuclei of invading cancer cells (Harada et al. 2014) and
has a number of consequences (introduced in Chapter 1).
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For one, constricted migration segregates mobile nuclear factors away from DNA
(Irianto et al. 2016a). Among cells in static culture, hetero/eu-chromatin occupies
roughly 50-70% of the nuclear volume per previous estimates from molecular mobility
(Bancaud et al. 2009), and Chapter 5 will show for various cancer cell lines that
the chromatin volume fraction can increase locally to 100% as the nucleus enters a
small constriction. Conversely, all mobile proteins in the nucleus, including those
that function as key DNA repair proteins, are always seen to deplete within the
constriction (Irianto et al. 2016a). Such unavoidable ‘squeeze-out’ of mobile nuclear
factors away from the constriction, where DNA concentration is highest, has important
implications for the repair of DNA damage that might occur during replication,
for example. Inactivating mutations in repair factors such as BRCA1 and BRCA2
are well-established risk factors for cancer and are sufficient cause for prophylactic
mastectomy (i.e. preventative surgery), and so transient partial depletion of such
factors could increase mutational probabilities.
In addition to inevitable squeeze-out of mobile repair factors, constriction can also
cause rupture of the nuclear lamina (Harada et al. 2014), to be further described
in Chapters 3 and 4. Studies with various cancer cell lines, immortalized epithelial
cells, and primary dendritic cells, show that migration through narrow channels
can rupture the nuclear envelope and thereby permit cytoplasmic accumulation of
GFP-tagged nuclear localization signal (NLS) constructs (Denais et al. 2016; Raab
et al. 2016). Rupture—and the ensuing nucleo-cytoplasmic exchange—occurs more
frequently after knockdown of lamin-A and is accompanied by focal enrichment of
endogenous DNA damage markers. The pan-nucleoplasmic distribution of the excess
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Figure 2.5: Cancer cells sustain severe nuclear stress during tumorigenic invasion into
small holes in stiff, fibrous tissues. This stress causes global loss of DNA repair factors via
both ‘squeeze-out’ and nuclear envelope rupture. Perhaps due to repair loss, migrated cells
exhibit elevated DNA damage, which ultimately leads to genome instability.

DNA damage foci suggests a global—rather than rupture site-specific—DNA damage
mechanism; this distribution is consistent with transient depletion of DNA repair
proteins (Irianto et al. 2016a, 2017). Such depletion—on the hours-long timescale
of migration—could delay repair of routine DNA breaks caused by various sources
(e.g. replication errors, oxidative stress), leading to the observed accumulation of
DNA damage in migrated cells.
Importantly, recent studies of DNA damage incurred during constricted migration
have also provided the first evidence of propagatable mutations. The genomes of serially
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migrated clones were analyzed by comparative genome hybridization arrays (aCGH),
single-nucleotide polymorphism arrays (SNPa), and whole-exome sequencing (as well
as RNA sequencing). Compared to unmigrated control clones, the migrated cells
exhibited elevated chromosome copy number changes (Irianto et al. 2017), suggesting
that such chromosome-level abnormalities are characteristic of constricted migration.
Recall that our meta-analysis showed that copy number changes and structural
variants scale with normal tissue stiffness, perhaps more so than somatic mutations
(Fig. 2.2, 2.3). Hence, constricted migration and stiffness seem to share a mutational
signature, namely large-scale genome instability. This signature also resembles that
of osteosarcomas and breast and ovarian cancers with BRCA deficiencies (Kovac
et al. 2015), although more such analysis is needed. Taken altogether, these genomic
analyses hint at a connection between stiffness, constricted migration, and repair factor
depletion (Fig. 2.5). Thus, these studies are consistent with the hypothesis that loss
of DNA repair during migration of cancer cells through small pores in fibrous matrix
could underlie the scaling relation between mutation rate and tissue stiffness (Fig. 2.1).

2.4

Conclusion

The meta-analysis here of recently published sequencing data reveals that somatic
mutation rate increases with normal tissue stiffness across cancer types, while the
rate of larger-scale, chromosome-level mutations increases even faster. Among various
hypotheses that seek to explain this scaling relationship, the one that we consider most
promising holds that stiffer tissues have smaller extracellular matrix pores, which can
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increase DNA damage in invading cancer cells, leading perhaps to genomic variation.
This hypothesis will be explored in the following chapters.
However, our first hypothesis in Section 2.3—that errors in division, coupled
somehow to tissue stiffness, give rise to genomic variation in cancer—also seems
promising, especially with further meta-analyses. Tomasetti and Vogelstein (Tomasetti
and Vogelstein 2015) showed that the lifetime cancer risk for a given tissue increases
with the lifetime number of stem cell divisions in that tissue. Whether we consider
the case of one-hit (oncogene) initiation of cancer or two-hit (tumor suppressor genes)
initiation, cancer risk scales with mutation probabilities (Nowak and Waclaw 2017).
Thus, across different cancer types, chromosomal variation and somatic mutation rate
increase with stiffness and division rate of normal tissues (Fig. 2.6). Furthermore,
stiffness and division rate seem to interact to generate genomic variation: as seen in Fig.
2.6B, mutation rate scales more strongly with stiffness in highly proliferative tissues
versus less proliferative tissues. Fig. 2.6A shows that, unlike other cancers of neural
lineage, melanoma develops in a stiff tissue with a high division rate; melanoma also
exhibits hugely elevated levels of chromosomal variation. Meanwhile, liquid tumors
have very low levels of chromosomal variation regardless of division rate, suggesting that
a stiff microenvironment might contribute by some unknown mechanism to replicative
errors, which then become permanent mutations. More study is needed to discern
mechanism, but 3D stiff surrounding could, for example, physically impact the fidelity
of replication and chromosome segregation during mitosis. These connections between
cell division, stiffness, and mutation help to motivate a careful accounting of cell cycle
and DNA damage after constricted migration, which is described in the next chapter.
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Figure 2.6: Across different cancer types, chromosomal variation and somatic mutation
rate increase with stiffness and division rate of normal tissues. (Continued next page.)
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Figure 2.6: (Previous page.) (A) (i) Copy-number heatmaps (showing arm-level somatic
copy-number alterations (SCNAs)) are displayed for 22 cancer types. Gains and losses are
on the same grayscale, normalized to maximum change; data from Beroukhim et al. (2010)
(Fig. A.1). Each heatmap was converted into an intensity profile (example: glioma, lower
inset), and the plotted ‘Cumulative Chr. Variation’ was calculated as total area under the
curve (=0.33 for glioma). Filled black points are binned means (±SEM) for solid tumors
fit with y = 0.29 + 0.0044x2 (R2 = 0.90); melanoma is not fit because its tissue stem cell
division rate is high (Tomasetti and Vogelstein 2015). The open black point indicates the
mean (±SEM) for the liquid tumors, which is below the trend line regardless of cell division
rate. (ii) Surface plot summary of the relationship between Cumulative Chr. Variation
and the stiffness and division rate of normal tissues. (B) Exactly as in Fig. 2.1, somatic
mutation rates are plotted against normal tissue stiffness. Dashed and solid lines are fit
to solid tumors in tissues with, respectively, high (black triangles) or medium-low (filled
black circles) rates of cell division. Division rates were approximated from Tomasetti and
Vogelstein (2015).
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3

Constricted migration increases DNA
damage and represses cell cycle
Chapters 1 and 2 introduced the idea that cell migration through dense tissues or
small capillaries can elongate and even damage the nucleus, with any effect on cell
cycle potentially impacting processes such as carcinogenesis. In this chapter, nuclear
rupture and DNA damage increase with constricted migration in different phases of
cell cycle—which we show is partially repressed. We study several cancer lines that are
contact inhibited or not and that exhibit diverse frequencies of nuclear lamina rupture
after migration through small pores. DNA repair factors mis-localize after migration,
and we consistently measure an excess of DNA damage based on pan-nucleoplasmic
foci of phospho-activated ATM and γH2AX. Foci counts are suppressed in late cell
cycle in agreement with expected checkpoints, and migration of contact-inhibited
cells through large pores into sparse microenvironments leads to cell cycle re-entry
and no effect on a basal level of damage foci. Constricting pores delay such re-entry
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while excess foci occur independent of cell cycle phase. Knockdown of repair factors
increases DNA damage independent of cell cycle, consistent with effects of constricted
migration. Because such migration causes DNA damage and impedes proliferation,
constricted migration illustrates “go or grow.”

3.1

Introduction

The growth of a cell mass can be suppressed through mechanisms of contact inhibition
(Morais et al. 2017) or physical crowding (Delarue et al. 2017), but invasive migration
of cells into nearby tissues or blood capillaries is expected to release such constraints
and permit DNA replication and mitosis (Fig. 3.1A). The so-called “go or grow”
hypothesis posits proliferation and cell migration to be mutually exclusive (Garay
et al. 2013; Giese et al. 1996), and it remains an open question whether or not a
cell that is impeded in migration as it squeezes through a narrow constriction is also
upregulating its cell cycle and replicative program.
Migration of cancer cell lines through small constricting pores has been seen—and
will be shown in this chapter—to increase DNA damage based on multiple measures,
including increased numbers of foci of phospho-Histone-2AX (i.e. γH2AX) in fixed
immunostained cells (Irianto et al. 2017). Replication often increases the basal level
of DNA damage in cells (Técher et al. 2017), so invasive migration might in principle
increase DNA damage simply by causing cell cycle re-entry (as cells move from a
crowded to a sparse microenvironment and are released from contact inhibition). At
the same time, rupture of the nuclear envelope after constricted migration causes
cytoplasmic mis-localization of key DNA repair factors (Irianto et al. 2017) as well
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Figure 3.1: Invasive migration can affect proliferation as well as nuclear integrity and
distribution of DNA and repair factors. (A) Invasion and proliferation are both hallmarks
of cancer. Invading cancer cells squeeze into regions of low cancer cell density, with cell
cycle re-entry possible from loss of contact inhibition. (B) Transwell membranes with small
or large cylindrical holes model invasive migration. Cells on top of the membrane at very
high density migrate over several hours to the bottom (a low-density environment). During
migration through constricting pores, cells exhibit frequent lamina rupture at sites of nuclear
blebs, followed by mis-localization of mobile nuclear proteins, including DNA repair proteins,
into the cytoplasm. (C) Super-resolution images show lamina disruption in the nuclear
blebs (white arrows) of three different cancer lines that have migrated through 3 µm pores.
(Representative of ≥5 cells per cell type.) % ‘bleb-positive’ refers to the proportion of each
cell type that exhibits blebs following 3 µm pore migration. In all cases, blebs are observed
at similar frequencies in 2N and 4N cells (≥150 cells per cell type, n = 2 expts).

as GFP-NLS constructs (Denais et al. 2016; Raab et al. 2016) (Fig. 3.1B), and
constricted migration also squeezes mobile nuclear proteins—including DNA repair
factors—away from chromatin that is strongly compacted in pores (Chapter 5, Irianto
et al. (2016a)). Given such perturbations to the repair of DNA damage in 3Dmigrated cells, an essential question for the field to address is whether cell cycle
changes and DNA replication help explain the observed excess of γH2AX foci that
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results from constricted migration.
Careful accounting of cell cycle and DNA damage after constricted migration is
further motivated by a previously noted correlation between DNA replication in a
given normal tissue’s stem cells and cancer risk in that tissue (Fig. 2.6, Fig. B.1A).
Such replication is, for example, higher in normal lung than in brain and much higher
than in bone, with ‘replicative’ cancer risk following the same trend. Cell cycle phases
also link to the repair of DNA damage in that cell cycle checkpoints require basal
levels of DNA damage to be sufficiently decreased via repair (Dasika et al. 1999). In
this chapter, studies of migration through small and large pores begin with a focus
on U251 glioblastoma cells, which are mesenchymal-like and not contact-inhibited
(Fuse et al. 2000), in comparison to two epithelial-like and contact-inhibited cancer
cell lines (A549 from lung, and U2OS from bone) that have already been studied
in constricted migration (Irianto et al. 2017). Because the porosity of tumors is in
the range of microns (Harada et al. 2014; Wolf et al. 2009), and the lumen of a
capillary can be as small as 3 µm (Sarveswaran et al. 2016), our studies use filters
with pore diameters of either 3 or 8 µm.

3.2
3.2.1

Results
Constricted migration consistently ruptures the nuclear
envelope, mis-localizes DNA repair factors, and increases
DNA damage

Migration through the 3 µm constricting pores takes hours, after which all three
cancer lines exhibit nuclear blebs (Fig. 3.1C). Such blebs were previously associated
with rupture of the nuclear envelope (Denais et al. 2016; Irianto et al. 2017; Raab
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Figure 2
Migration-induced nuclear rupture leads to mis-localization of DNA repair factors and pan-nucleoplasmic DNA damage
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Figure 3.2: Constricted migration causes varying degrees of nuclear rupture but consistently
mis-localizes repair factors and increases DNA damage. (Continued next page.)
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Figure 3.2: (Previous page.) (A) (i) Confocal images of U251 cells show that mobile
nuclear proteins, including the DNA repair factor KU80, are often observed outside the
boundary of the DNA edge in cells that have migrated through 3 µm pores (‘3 µm bottom’).
Such mis-localization, indicative of nuclear rupture, is rarely seen among unmigrated cells
(‘3 µm top’). (ii) Across three cancer cell lines that have squeezed through 3 µm pores, cells
like those in panel (i) that show obvious mis-localization of KU80 (‘KU80 leakage’) have
lower levels of KU80 in their nuclei than cells without obvious mis-localization. Rupture
causes a net loss of nuclear KU80 but not lamin-B. Asterisks indicate a significant difference
(p < 0.05) in total nuclear intensity (≥8 cells per condition, error bars = SEM). (B) (i)
Schematic showing that constriction-induced mis-localization of repair factors physically
inhibits repair of DNA breaks, leading perhaps to an excess of DNA damage above the basal
level. (ii) Super-resolution images of a representative formaldehyde-fixed, immuno-stained
U251 cell show pan-nucleoplasmic 53BP1 foci that appear to mostly overlap with γH2AX
foci. However, higher magnification insets reveal heterogeneity within individual foci. (C)
U251, U2OS, and A549 cells exhibit diverse frequencies of lamina rupture following 3 µm
pore migration (as indicated by the percent of migrated cells with blebs), but all exhibit
a constriction-induced increase in the proportion of cytoplasmic (versus nucleoplasmic)
endogenous KU80 as well as an increase in γH2AX foci. Asterisks indicate a significant
difference (p < 0.05) in % total KU80 signal or γH2AX foci (≥100 cells per condition, n =
2 expts, error bars = SEM).

et al. 2016) and are seen here in all cancer lines to be independent of low or high DNA
content (designated simply as ‘2N’ or ‘4N’ content). Only a minor fraction (∼15%) of
mesenchymal U251 nuclei exhibit visible blebs compared to the more epithelial-like
cell lines (∼60-80%). Super-resolution microscopy nonetheless indicates a common
bleb structure with near complete loss of lamin-B as well as dilated webs of lamin-A
(Fig. 3.1C). Larger pores of 8 µm rarely generate such blebs.
After constricted migration, immunostaining shows mis-localization of the endogenous DNA repair factor KU80, with abundant KU80 in the cytoplasm (Fig.
3.2A-i) and net loss of KU80 from the nucleus (Fig. 3.2A-ii). Such migration-induced
mis-localization of DNA repair factors could in principle delay the repair of DNA
breaks (Fig. 3.2B-i). To begin to assess DNA damage and repair, super-resolution
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Figure 3
Phospho-activated ATM (pATM) foci are fewer in number but co-localize with the larger H2AX foci
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Figure 3.3: Phospho-activated ATM (pATM) is an upstream kinase for γH2AX in the
DNA damage response pathway, and pATM foci co-localize with γH2AX foci, which are
suppressed in late cell cycle. (Continued next page.)
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Figure 3.3: (Previous page.) (A) (i) DNA damage activates ATM through auto- or
trans-phosphorylation. Activated ATM then mediates the phosphorylation of histone H2AX,
yielding γH2AX. (ii) Treatment of unmigrated U2OS cells with an ATM inhibitor (ATMi)
suppresses formation of phospho-activated ATM (pATM) foci as well as γH2AX foci,
consistent with ATM being an upstream kinase for γH2AX in the DNA damage response
signaling pathway. Note that the number of γH2AX foci is lower here than in other figures
because these cells were imaged at low magnification, making it difficult to visualize the
smallest foci (≥99 cells per condition, error bars = SEM). (iii) In confocal images of U2OS
cells, foci of pATM co-localize with γH2AX foci, though the latter are larger and more
numerous. The distribution of foci is pan-nucleoplasmic in both migrated (‘3 µm bottom’)
and unmigrated (‘3 µm top’) cells. Scatter plots show that number of γH2AX foci increases
with number of pATM foci for both 2N and 4N cells. There is an overall increase in foci after
migration (inset) (≥160 cells per condition, error bars = SEM). (B) (i) Schematic illustrates
the EdU cell proliferation assay that was used to assess the impact of 3 µm pore migration
on cell cycle progression. Immediately following a 24-hour migration period, EdU was added
to the transwell membrane (or 2D culture) for 1 h before the usual fixation and staining
procedure. EdU-labeled cells were stained by a ‘click’ chemistry reaction that is compatible
with immunohistochemical staining of other antigens. (ii) As shown in this representative
plot, the EdU and DNA intensity of individual cells—measured by immunofluorescence
microscopy—can be used to classify the cells as 2N or 4N and, further, as G1, early S (eS),
late S (lS), or G2. Plot shows cells on the top of an 8 µm pore membrane. (iii) Cells in late
phases of cell cycle (lS, G2, M) exhibit fewer γH2AX foci per total DNA than cells in early
phases (G1, eS). U251 images show cells on the top of an 8 γm pore membrane. Across all
experimental conditions, U251 cells in late S have an average of 0.8× as many γH2AX foci
per DNA as U251 cells in G1; cells in G2 have 0.65× as many; and mitotic cells have 0.4×
as many. Trends are similar for U2OS cells and A549 cells (adhering on bottom of transwell)
(Figure B.2; ≥60 cells per condition, n = 2 expts).

imaging was applied to pore-migrated U251 nuclei (Fig. 3.2B-ii). Images show pannucleoplasmic foci of anti-γH2AX and anti-53BP1, and these two markers of DNA
repair are known to often co-localize at sites of DNA damage (Denais et al. 2016;
Raab et al. 2016). Accumulations of overexpressed 53BP1-GFP and RFP-53BP1 have
been reported previously as evidence of constriction-induced DNA damage (Denais
et al. 2016; Raab et al. 2016), but such overexpressed fusions segregate from DNA
(Irianto et al. 2016a), and anti-53BP1 is less reliable for quantifying DNA damage
than anti-γH2AX (D’Abrantes et al. 2018). Here, quantitative analyses of γH2AX foci
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in conventional confocal images show significantly higher foci counts above a basal
level of DNA damage for all three cancer lines after constricted migration through 3
µm pores (Fig. 3.2C). Despite the >4-fold range in nuclear bleb frequency, all three
cell lines also show a similar level of repair factor mis-localization to the cytoplasm.
Migration through large pores does not cause nuclear blebs, KU80 mis-localization,
or excess DNA damage in any cancer line. Furthermore, constricted migration of
all cancer lines also leads to very low cell densities (bottom, Fig. 3.2C), which has
important implications for cell cycle re-entry, DNA replication, and potential coupling
to DNA damage (Técher et al. 2017).
An alternative hypothesis to the loss of repair factors is that nuclear constriction
itself activates the DNA damage response signaling pathway: ATR kinase reportedly
localizes to sites of nuclear deformation, as during pipette aspiration (Kumar et al.
2014). ATM is a related kinase that phosphorylates histone H2AX, yielding γH2AX,
in response to DNA damage (Burma et al. 2001) (Fig. 3.3A-i,ii). If ATM were
mechanoresponsive in the same way as ATR, one might expect to see stress-induced
local accumulations of phospho-activated ATM (pATM) during pore migration.
However, we find that pATM foci are similar in appearance and pan-nucleoplasmic
distribution to γH2AX foci both on top and on bottom of 3 µm pore filters (Fig.
3.3A-iii). pATM foci are fewer in number than γH2AX foci, consistent with ATM being
a key upstream kinase for γH2AX as a longer-lived substrate. The pan-nucleoplasmic
foci (of both pATM and γH2AX) thus likely mark DNA breaks as is usually reported,
especially because their numbers correlate with the results of electrophoretic comet
assays that measure DNA breaks (Irianto et al. 2017). In the process of counting foci
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and finding that both pATM and γH2AX increase after migration, we also noticed
a tendency for more foci in late phase nuclei, which prompted scrutiny of cell cycle
effects on the excess damage. The role of cell cycle in migration-induced DNA damage
is not yet known: excess damage could be a trivial consequence, for example, of
contact-inhibited cells re-initiating replication that incurs damage.

3.2.2

Constricted migration perturbs cell cycle, but this perturbation does not explain migration-induced DNA damage

Cell cycle analyses on the various cells before and after migration (Fig. 3.3B-i) were
done by fluorescence imaging of both DNA content and integration of the thymidine
analogue 5-ethynyl-20 -deoxyuridine (EdU) into newly synthesized DNA (Fig. 3.3B-ii)
(Salic and Mitchison 2008). Conventional designations for non-replicated genomes
(‘2N’) and the twice-larger, fully replicated genomes (‘4N’) are used again for simplicity
despite the aneuploid nature of typical cancer genomes. Counts of γH2AX foci were
normalized to total DNA content and then compared to G1, which shows that DNA
damage decreases in late phases of the cell cycle, including late S (lS), G2, and M
(Fig. 3.3B-iii, Fig. B.2A). This decrease is consistent with well-known cell cycle
checkpoints for DNA damage (Dasika et al. 1999). Foci in mitosis are sometimes
symmetric between daughters, which suggests inherited damage rather than random
immunolabeling. The results add confidence to the measurements of DNA damage foci
and also begin to suggest that the excess DNA damage occurs independent of cell cycle.
The identifications of cell cycle phases further revealed that constricted migration
suppresses the fraction of cells in late cell cycle (Fig. 3.4A-i). Although it is clear that
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Figure 4
Constricting pores cause a decrease in the proportion of G2 and M cells
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Figure 3.4: Constricted migration perturbs cell cycle. (Continued next page.)
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Figure 3.4: (Previous page.) (A) U251, U2OS, and A549 cells were seeded at three different
densities (low, medium, high) on 2D plastic and were also migrated through 3 µm and 8 µm
pore membranes. In each case, cell cycle analysis was performed using total DNA content
combined with EdU incorporation, as described in Fig. 3.3 and as depicted here in panel
(i). (ii) Epithelial-like A549 and U2OS cells seem to experience stronger contact inhibition
than mesenchymal-like U251 cells. Density and % 4N were measured for (non-migrated)
cells in 2D and on top of transwell membranes (≥70 cells per density condition for each
cell type). (iii-iv) Constricted migration causes a decrease in the proportion of G2 cells
for every cancer cell line studied, whether or not the cell line exhibits contact inhibition.
Migration through the larger pores is consistent with cell cycle progression, with more cells
in G2 phase compared to the small pores. Red lines are fits to 2D data points. Asterisks
indicate a significant difference (p < 0.05) in % G2 between ‘3 µm bottom’ cells and either
sparse 2D cells (U251) or ‘8 µm bottom’ cells (U2OS and A549) (≥60 cells per condition, n
= 2 expts, error bars = SEM). (B) Starting with contact-inhibited cells, migration through
large pores into sparse microenvironments releases contact inhibition and enables cell cycle
re-entry, whereas constricted migration represses entry into late S/G2/M despite low density.
U2OS cells were plated at high density for 48 h to loosely synchronize them in G1/eS phase.
After 48 hours, the cells were trypsinized; a portion of them were seeded on 3 and 8 µm TW
membranes, and then allowed to migrate for 8 or 24 h. Another portion of the cells were
seeded at three different densities (high, med, low) in 2D, and then incubated for either 0, 8,
or 24 hours. Migration through 8 µm pores causes an increase in the 4N population as cells
move from high density on top of the transwell membrane (right-most plot, contact-inhibited)
to low density on the bottom (middle plot). Migration through 3 µm pores, despite also
alleviating contact inhibition, delays entry into 4N over at least 8 h. Asterisks indicate a
significant difference (p < 0.05) in % 4N between ‘3 µm bottom’ cells and ‘8 µm bottom’
cells (≥95 cells per condition, error bars = SEM).

U251 cells are not contact-inhibited (Fuse et al. 2000) and thus differ as expected from
the A549 and U2OS cells in this respect (Fig. 3.4A-ii), all of the cancer lines studied
show G2 and M phases are suppressed after constricted migration (Fig. 3.4A-iii,iv,
Fig. B.2B). With large pores, in contrast, migration from high density (‘Top’) to low
density (‘Bottom’) leads to cell cycle re-entry for the contact-inhibited cells (A549
and U2OS), with more cells in S/G2/M phases after migration.
To exert more control over cell cycle, U2OS cells were cultured prior to migration
at very high density for 48 h, which biases toward G1/eS. U2OS cells are not only
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Figure 5
Excess H2AX foci after constricted migration are not merely a consequence of cell cycle perturbation
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Figure 3.5: Cell cycle perturbation does not explain constriction-induced increases in DNA
damage. (Continued next page.)

contact inhibited but also exhibit an intermediate amount of migration-induced DNA
damage (Fig. 3.2C). In 2D sparse cultures, the fraction of 4N cells decays in ∼8 h
toward the contact-inhibited state. When re-plated at high density above large pores
of 8 µm, the cells migrate through to a low-density state and clearly re-enter cell
cycle by ∼8 h based on a greater fraction of 4N cells (Fig. 3.4B). These results are
consistent with release from the contact inhibition on Top, whereas 3 µm constricting
pores effectively repress cell cycle, with far fewer 4N cells after 8 h. The result is
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Figure 3.5: (Previous page.) (A) For each cell type, and for each experimental condition
(i.e. 3 µm/8 µm, top/bottom, 2D low/med/high), the average number of γH2AX foci was
calculated for every phase of the cell cycle (G1, eS, lS, G2, M), and then normalized to
the the average number of γH2AX foci in G1. These normalized values were then averaged
across all experimental conditions (Figure B.3B; ≥60 cells per condition, n = 2 expts,
error bars = SEM). Based on these foci-per-phase averages (γphase), along with the cell
cycle distributions from Fig. 3.4A-iii (%phase), the “predicted” number of γH2AX foci per
nucleus was calculated for 3 µm and 8 µm top and bottom. This number is essentially a
weighted average of γH2AX foci. Then, for both 3 µm and 8 µm, the measured (bottom/top)
γH2AX foci ratio was plotted against the predicted foci ratio. Across all cell types, the
3 µm measured ratio is much larger than the predicted ratio, meaning that excess foci
after constriction cannot be explained away as a consequence of perturbations to cell cycle
distribution. Note that the measured foci ratio for U2OS cells is not equal to the ratio
reported in Fig. 3.2C. The foci data in these two figures come from two different migration
experiments; as shown below in Fig. 3.5B-i, there is some inter-experiment variability in
foci ratio, but there are always statistically more foci on bottom than top. (B) In eight
separate U2OS transwell migration experiments, cells were measured for γH2AX foci number
and, based on total DNA content, classified as 2N or 4N. Plots show average values of
(bottom/top) γH2AX foci ratio and foci per DNA ratio for these eight experiments. All
experiments adhere to the trends reported here, with cells in early and late stages of the
cell cycle accruing similar excesses of γH2AX foci during constricted migration. Of the
eight experiments, the maximum 2N γH2AX foci ratio is indicated by a red dash; the
corresponding 4N ratio for the same experiment is likewise indicated. Minimum 2N (cyan),
maximum 4N (purple), and minimum 4N (green) ratios are also reported. The gray interval
extends from the minimum to the maximum 2N ratio; this bar is repeated in all µH2AX
foci ratio plots in subsequent figures. Averaging across all eight experiments, there is no
significant difference in foci ratio between 2N and 4N cells for either 3 µm or 8 µm (p > 0.05
in every case, ≥60 cells per condition, n = 8 expts, error bars = SEM).

consistent with transient repression of G2/M phases (Fig. 3.4A-iii,iv).
Migration-induced changes in cell cycle distribution should affect the average
number of γH2AX foci per nucleus given that late cell cycle phases show different
numbers of foci than early cell cycle phases (e.g. Fig. 3.3B-iii, Fig. B.2A). However,
the predicted change in foci number due to cell cycle perturbation is small compared
to the actual measured excess of DNA damage after constricted migration (Fig. 3.5A).
For example, for U251 cells, we predict a ‘Bottom’-to-‘Top’ γH2AX foci ratio of
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1.01 due to cell cycle perturbations alone, but the actual measured ratio is ∼1.3.
Importantly, this result means that the increase in γH2AX foci after constricted
migration is not trivially due to changes in the cell cycle distribution.
Across eight separate migration experiments, constricting pores always cause an
excess of DNA damage in the 4N population even though they deplete this population
(Fig. 3.5B, B.3A). Moreover, the excess DNA damage shows the same fold-increase
in 2N and 4N cells after constricted migration (Fig. 3.5B). Larger pores do not
cause an increase in DNA damage for either 2N or 4N cells. These findings suggest
that migration-induced DNA damage occurs independent of cell phase and hence
independent of replication. In support of this conclusion, BRCA1 is expressed in a
cell cycle-dependent way, with BRCA1 foci increasing strongly with replication in
S-phase (Feng et al. 2013), so we might expect to see large excesses of BRCA1 foci
on ‘Bottom’ if migration-induced damage were replication-dependent. However, the
measured increases in BRCA1 foci after constricted migration match the predicted
increases when accounting for cell cycle perturbations (Fig. B.3B). Furthermore,
topoisomerase (TOP2A) is one source of DNA breaks in replication, but while its
partial knockdown decreases γH2AX foci counts on ‘Top’ (before migration), the
knockdown does not significantly affect γH2AX foci counts after constricted migration
(Fig. B.4A). Migration-induced DNA damage thus does not depend on topoisomerase
activity, which is consistent with the above conclusion that the excess damage arises
by some mechanism(s) other than replication stress.
Blocking DNA synthesis and mitosis with a CDK4/6 inhibitor (PD: palbociclib, 10
µM for 72 h (Bollard et al. 2017)) effectively ‘locks’ cells in G1 or G2 (Fig. B.5A), and
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unlike other cell cycle inhibitors this drug does not directly damage DNA. Washout
of PD prior to migration studies should allow cells to re-enter S-phase and become
EdU-positive (Fig. 3.6A-i). Constricted migration again delays entry into S phase
whereas migration through large pores has the opposite effect (Fig. 3.6A-ii,iii). The
latter result is consistent with release from contact inhibition as G1 cells at high
density migrate to low density (Fig. B.5B). Importantly, the excess γH2AX foci after
constricted migration of the PD-washout cells (Fig. 3.6A-iv) agrees quantitatively
with control cells (Fig. 3.2C). Excess DNA damage in both early and late phases of
cell cycle is also evident for small pores (Fig. 3.6A-v). The results thus suggest that
the constriction-induced excess in DNA damage is independent of DNA replication.
Maintaining PD during pore migration (Fig. 3.6B-i) clarifies that G1 and G2
cells migrate at similar rates (Fig. 3.6B-ii). Replication is also uniformly blocked
as expected (Fig. 3.6B-iii). Deficits of G2/M cells in constricted migration of cells
not treated with any drug (Fig. 3.4A-iii,iv) are therefore not due to selection for G1
cells. Likewise, increases in G2/M cells in large pore migration of cells not treated
with any drug (Fig. 3.4A-iii,iv) are not due to selection for G2 cells.

3.2.3

Inhibiting DNA repair causes excess DNA damage independent of cell cycle

A direct assessment was needed to determine whether partial loss of multiple DNA
repair factors—as occurs during constricted migration via both exclusion and rupture
(Fig. 3.1B, 3.2A-i)—can cause excess DNA damage in both 2N and 4N cells as seen
during constricted migration (Fig. 3.5B-i, 3.6A-v). Partial knockdown of four key
repair proteins KU80, BRCA1, BRCA2, and RPA1 (Fig. 3.7A) that exhibit different
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Figure 6
Inhibiting replication maximizes G1 and G2, which incur similar migration-induced DNA damage
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Figure 3.6: (Previous page.) (A) (i) U2OS cells were treated with 10 µM palbociclib
(PD), a CDK4/6 inhibitor, for 72 hours to ‘freeze’ cells in either G1 or G2. The drug was
then washed out, and the cells were migrated through 3 and 8 µm pores for 24 hours. (ii)
Non-migrated cells (‘Top’) and cells that migrated through small (3 µm ‘Bot’) or large (8 µm
‘Bot’) pores show similar cell cycle distributions, suggesting that the pores do not select for
cells in particular phases of the cell cycle. (iii) EdU staining indicates that G1-synchronized
cells show reduced entry into S phase after migration through constricting pores. On the
other hand, migration through larger 8 µm pores to a low-density environment causes
release of contact inhibition and an increase in S phase cells. The gray interval indicates
% EdU-positive on ‘Top’. (iv) PD wash-out cells exhibit excess γH2AX foci after 3 µm
pore migration (p < 1×10−4 ), similar to non-treated. There is also a very slight but still
significant foci increase after 8 µm pore migration (p = 0.03). Asterisks indicate significance.
(v) The excess γH2AX foci occur in both 2N and 4N cells; there is no significant difference
in foci ratio between 2N and 4N cells for either 3 µm or 8 µm. Given the low incidence
of S phase cells due to PD treatment, the 2N and 4N populations are dominated in this
case by G1 and G2 cells, respectively (≥130 cells per condition, n = 2 expts, error bars =
SEM).(B) U2OS cells were treated with 10 µM PD for 72 hours, and then migrated—with
sustained drug—through 3 and 8 µm pores for 24 hours. Measurements were made of cell
cycle distribution and percent EdU-positive cells, as described above in A (≥75 cells per
condition, n = 2 expts, error bars = SEM).

activities throughout the cell cycle indeed causes a large increase in γH2AX foci even
in non-migrated (Top) cells (Fig. 3.7B-i, ii). In both 2N and 4N cells, the excess DNA
damage in the ‘si4’ knockdown cells occurs equally on Top and Bottom (Fig. 3.7B-ii),
perhaps because the high number of foci in si4 nuclei reflects a “maximum,” and cells
with even more severe damage tend to apoptose and go undetected. The increase
in γH2AX foci after migration is once again the same for 2N and 4N cells, whether
non-treated, siCtrl, or si4 cells (Fig. 3.7B-iii). The experiment thus confirms that
damage due to loss of repair factors arises throughout the cell cycle, not just in S phase.
Finally, we took advantage of a U2OS clone that overexpresses by ∼2-fold the
transcription factor GATA4; GATA4 mediates microtubule assembly, and its upregulation gives the clone an elongated shape similar to that of mesenchymal stem cells
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Figure 3.7: (Previous page.) (A) U2OS cells were treated with a single siRNA pool of
BRCA1, BRCA2, RPA1, and KU80, leading to a >50% knockdown (KD) of these factors,
as seen by western blot (i) and immunofluorescence microscopy (ii).(B) (i) si4 KD cells,
along with non-treated and siCtrl cells, were migrated through 3 µm pores for 24 hours. (ii)
Treating U2OS cells with single siRNAs leads to excess γH2AX foci among non-migrated
(‘Top’) 2N and 4N cells. Constricted migration apparently does not cause a further increase
in γH2AX foci among si4 cells, possibly because cells with even more severe damage tend
to apoptose and go undetected. Asterisks indicate a significant difference (p < 0.005) in
γH2AX foci between ‘Bottom’ and ‘Top’ cells; the difference is not significant for 4N siCtrl
cells (p = 0.1). (iii) The fold increase in γH2AX foci after migration is the same for 2N
and 4N si4 cells, just as it is for non-treated and siCtrl cells (p > 0.05 in every case). Note
that the measured foci ratio for 2N siCtrl cells is not equal to the ratio for NT cells. This
discrepancy seems more likely to be due to variability between experiments, as documented
in Fig. 3.5B-i, than to any effect of the siCtrl given that the siTOP2A experiment (Fig.
B.4A) shows siCtrl behavior that is much more similar to NT (≥35 cells per condition, error
bars = SEM). (C) (i) Compared to rounder cell types, cell types that have more elongated
nuclei in sparse culture exhibit blebs at lower frequency after 3 µm pore migration. The
“spindle-shaped U2OS clone” has an elongated, stable MSC-like shape due to upregulation
of the transcription factor GATA4, which mediates microtubule assembly (Rivera-Feliciano
et al. 2009). Aspect ratio values were averaged across 2D low-density and 3 µm bottom
conditions. Asterisks indicate a significant difference in % bleb-positive (p = 0.01) and
nuclear aspect ratio (p = 0.01) between U2OS bulk and U2OS spindle-shaped clone cells
(≥150 cells per cell type, n = 2 expts, error bars = SEM). (ii) Schematic illustrates a round
nucleus (upper) and a more elongated nucleus (lower) squeezing into a narrow pore. Since
the nuclear envelope can support pressure gradients over hours-long timescales (Petrie et al.
2014), there should be no significant flow of fluid across the envelope during migration, and
the nuclear volume—which is the same for the round and elongated nuclei—is conserved.
When the migrating nucleus is spherical, any deformation that conserves the volume must
increase the surface area of the nuclear envelope and lamina, constituting lamina dilation.
Because the lower nucleus is already elongated prior to migration, the same initial area Ai
has already grown to a slightly larger initial area A0i . Thus, the change in area ∆A0i = Af A0i is smaller than ∆A = Af - Ai meaning perhaps less severe lamina dilation for the more
elongated nucleus. (D) Plots refer to 3 µm pore migration. (i) Like bulk U2OS cells, the
spindle-shaped U2OS clone shows similar migration-induced excesses of γH2AX foci in early
and late phases of the cell cycle. (ii) The clone migrates nearly twice as fast as U2OS bulk
but exhibits the same % 4N after migration (≥120 cells per cell type, error bars = SEM).

(MSCs) (Irianto et al. 2017). Compared to bulk U2OS cells, this spindle-shaped
U2OS clone has a higher nuclear aspect ratio in sparse culture and also exhibits blebs
with significantly lower frequency after 3 µm pore migration (Fig. 3.7C-i). Normal,
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primary MSCs also show a low tendency to bleb (∼15% (Irianto et al. 2017)), which
supports the idea that an elongated nuclear shape minimizes lamina dilation and
disruption upon constriction (Fig. 3.7C-ii). Like U2OS bulk cells, the spindle-shaped
U2OS clone shows nonetheless a ∼1.5-fold increase in γH2AX foci after migration
through 3 µm pores, with the damage occurring at similar rates in both early and
late phases of the cell cycle (Fig. 3.7D-i). After a 24 hour-long migration period, the
number of spindle-shaped clone cells on the bottom of a 3 µm pore membrane is twice
that observed for bulk U2OS; however, the clone shows the same (low) proportion
of 4N cells (Fig. 3.7D-ii). Thus, the clone’s higher cell density on ‘3 µm bottom’ is
likely due to a migratory rather than a proliferative advantage, especially because
these cells have the same doubling time as bulk U2OS in 2D culture (Irianto et al.
2017). Spindle-shaped clone cells, like U2OS bulk cells, “go then grow,” with the
noted delay in the “grow” phase after constriction.

3.3

Discussion

Small pores (3 µm) squeeze the chromatin, dilute the lamina, and rupture nuclei
unlike large pores (8 µm) (Fig. 3.1, 3.2A, 3.2C). Related to these processes but not
strictly coupled to nuclear blebbing, many key regulators of DNA, including repair
factors, mis-localize (Fig. 3.2A,3.2C); depletion of repair factors provides one possible
mechanism for an excess of γH2AX foci observed only with small pores (Irianto
et al. 2017). Importantly, such excess DNA damage occurs equally in early and
late phases of cell cycle even in the absence of replication (Fig. 3.5B, 3.6A, 3.7B).
Large pores and small pores also show opposite effects on cell cycle, with small pores
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always suppressing G2/M phases (Fig. 3.4, 3.6A) without selection (Fig. 3.6B). By
contrast, when contact-inhibited cells migrate through large pores from high-density
to low-density environments, they are able to spread and re-enter cell cycle as expected
(Fig. 3.4, 3.6A). The latter process might seem intuitive (Fig. 3.1A), and yet the
increased replication—which can increase the basal level of DNA damage in cells
(Técher et al. 2017)—does not lead to significantly more DNA damage foci of γH2AX
after migration through large pores (Fig. 3.5A). Blocking replication in migration
through both small pores and large pores yields the same results for DNA damage
as with untreated cells. The results ultimately address a key question about 3D
migration in showing that cell cycle and DNA replication do not explain the excess
in DNA damage that results from constricted migration.
Migration through small rings has been described as somehow selecting for G1/eS
cells (Panagiotakopoulou et al. 2016), but PD blockade (Fig. 3.6) indicates no
selection of G1 versus G2 cells in constricted migration through long pores. Without
such blockade, cells need to repair DNA damage sufficiently in order to progress
through cell cycle (Dasika et al. 1999), and indeed later phases of the cell cycle
exhibit fewer damage foci per DNA even after constricted migration (Fig. 3.3B-iii,
Fig. B.2). Documentation of this expected trend—of decreasing DNA damage in
later cell cycle—adds confidence to our classification of cell cycle phases and to our
counting of γH2AX foci. Adding DNA damage during S phase with the drug etoposide
requires repair factors to fix the excess damage (Irianto et al. 2017) and thus affects
cell cycle, but etoposide does not affect cell numbers that migrate through small
pores, including both 2N and 4N cells (Fig. B.4B).
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Interestingly, the mesenchymal-like U251 cells exhibit migration-induced nuclear
blebs at a similarly low frequency (∼15%) to primary MSCs (Irianto et al. 2017),
which is far below the frequency of the epithelial-like A549 and U2OS cells (∼60-80%)
(Fig. 3.1A-iii, 3.2C). MSCs have a normal diploid genome unlike the cancer lines, so
differences in nuclear bleb frequency could be physical rather than cancer-related. The
% bleb-positive nuclei seems to trend with the resting shapes of cells and their nuclei
in sparse culture, with more elongated nuclei exhibiting a lower rate of bleb formation
(Fig. 3.7C-i). It is tempting to propose that lamin levels might explain the rate of bleb
formation given that U251 cells are notably low in lamin-A (Swift et al. 2013), but
MSCs have very high levels of lamin-A (Harada et al. 2014), and the spindle-shaped
U2OS clone has wild-type levels, meaning that lamin abundance does not easily explain
% blebbing. In contrast, a nuclear shape more elongated than those studied here could
slip through a small pore unscathed—which probably applies to neutrophils (Irianto
et al. 2017). Importantly, while nuclear blebs provide a relatively clear indication of
nuclear envelope rupture, they might also underestimate processes of nuclear factor
mis-localization. After constricted migration, all cancer lines exhibit a similar level of
DNA repair factor mis-localization to cytoplasm as well as an excess of DNA damage
(Fig. 3.2C), and the latter was also observed for primary MSCs (Irianto et al. 2017).
Our findings are also relevant to the so-called “go or grow” hypothesis that
is long-debated in cancer research and posits that proliferation and migration are
spatiotemporally exclusive events (Garay et al. 2013; Giese et al. 1996). Our results
for constricted migration indicate that additional mutation-relevant processes are
involved in a “go, damage, and then grow” behavior: the spindle-shaped U2OS
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clone migrates twice as fast as U2OS bulk cells but shows the same DNA damage
and repressed % 4N after migration (Fig. 3.7D). The surprising delay in growth
would not be evident in 2D nor in soft 3D environments but has implications for
the invasive migration of cancer cells away from a tumor mass and into nearby stiff
tissues or blood capillaries (Fig. 3.1A-i).
Lastly, as discussed in Chapter 2, cancer risk has been reported to correlate with
DNA replication (via mutation errors) in tissue-resident stem cells (Tomasetti and
Vogelstein 2015). However, the correlation is weak (R2 = 0.6) which has suggested to
many that additional mechanisms contribute to mutations (Nowak and Waclaw 2017)
(Fig. B.1B-B.1C). Genomic variation increases after migration of cancer cells through
rigid constricting pores (Irianto et al. 2017), and the results here support such a cell
cycle-independent process in stiff tissue as an orthogonal mechanism of cancer risk.

3.4

Materials and methods

Cell culture

U2OS human osteosarcoma and U251 human glioblastoma cells were

cultured in DMEM high glucose medium (Gibco, Life Technologies), supplemented
with 10% FBS and 1% penicillin/streptomycin (MilliporeSigma). A549 human lung
cancer epithelial cells were cultured in supplemented Ham’s F12 medium (Gibco, Life
Technologies). A549 cells with endogenously GFP-tagged CTNNB1 and RFP-tagged
LMNB1 were purchased from MilliporeSigma. The U2OS spindle-shaped clone was
generated by 17 consecutive migrations of wild-type clonal U2OS cells through 3
µm pores, as described in (Irianto et al. 2017). A k-means clustering analysis of
mRNA levels—combined with functional analyses of the transcript changes by DAVID
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Bioinformatics 6.7 (Huang et al. 2009)—revealed the clone to be enriched for the
microtubule cytoskeletal system, notably the transcription factor GATA4. For cell
cycle control experiments, 10 µM of the CDK4/6 inhibitor PD: palbociclib (Cayman
Chemical) was added to 2D cell culture for 72 hours prior to transwell migration
(described below). For topoisomerase experiments, 10 µM of the topoisomerase II
poison etoposide (MilliporeSigma) was maintained at the top and bottom of the
transwell membrane during migration.
Transfection

GFP-53BP1 was a gift from Dr. Roger Greenberg of the University

of Pennsylvania (Cho et al. 2015).

We used small interfering RNAs (siRNAs)

purchased from Santa Cruz (siTOP2A, sc-36695) and Dharmacon (ON-TARGETplus
SMARTpool siBRCA1, L-003461-00; siBRCA2, L-003462-00; siKu80, L-010491-00;
siRPA1, L-015749-01; and non-targeting siRNA, D-001810-10). We transfected either
siTOP2A (30 nM), pooled siRNA oligos (25 nM; four siRNAs/target), or GFP-53BP1
(0.5 ng/mL) with 1 µg/mL Lipofectamine 2000 (Invitrogen, Life Technologies) for
72 hours (siRNA) or 24 hours (GFP) in corresponding media, supplemented with
10% FBS. Knockdown efficiencies of siTOP2A and siBRCA1 were determined by
immunofluorescence microscopy; knockdown efficiencies of siBRCA2, siKU80, and
siRPA1 were determined by western blot via standard methods.
Transwell migration

Migration assays used 24-well inserts with 3 µm or 8 µm

pore filters. Cells were first detached, and then seeded on top of a transwell membrane
(Corning) at a density of 4.5 × 105 cells/cm2 . Medium supplemented with 10% FBS
and 1% penicillin/streptomycin was added to the top and bottom of the membrane
such that no nutrient gradient was established. After 24-hour incubation (unless
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otherwise noted) at 37◦ C and 5% CO2 , transwell membranes were formaldehyde-fixed
and stained as described below.
Immunostaining and imaging

Cells were: (1) fixed in 4% formaldehyde (Mil-

liporeSigma) for 15 minutes; (2) permeabilized by 0.25% Triton-X (MilliporeSigma)
for 10 minutes, and (3) blocked with 5% BSA (MilliporeSigma) for 30 minutes, all
at room temperature. Then, cells were incubated in primary antibodies overnight
at 4◦ C. The antibodies used include lamin-A/C (Santa Cruz and Cell Signaling),
Lamin-B (Santa Cruz), KU80 (Cell Signaling), γH2AX (MilliporeSigma), 53BP1
(Abcam), phosphorylated S1981 ATM (Abcam), topoisomerase IIα (Santa Cruz),
BRCA1 (Santa Cruz), BRCA2 (MilliporeSigma), and RPA1 (Santa Cruz). Finally,
cells were incubated in secondary antibodies (Thermo Fisher) for 1.5 hours, and their
nuclei were stained with 8 µM Hoechst 33342 (Thermo Fisher) for 15 minutes, all at
room temperature. Cells were mounted with Prolong Gold antifade reagent (Invitrogen,
Life Technologies). Epifluorescence imaging was performed on an Olympus IX71—with
a 40×/0.6 NA objective—and a digital EMCCD camera (Cascade, Photometrics). For
confocal imaging, we used a Leica TCS SP8 system, equipped with either a 63×/1.4 NA
oil-immersion or a 40×/1.2 NA water-immersion objective. Super-resolution images
were taken using a Leica TCS SP8 STED 3X system with a 100×/1.4 NA oil-immersion
objective. ImageJ (Schneider et al. 2012) was used to quantify the resulting images.
EdU labeling and staining

EdU (10 µM, Abcam) was added to 2D culture or

transwell membrane 1 hour before fixation and permeabilization. After permeabilization, samples were stained with 100 mM Tris (pH 8.5) (MilliporeSigma), 1 mM
CuSO4 (MilliporeSigma), 100 µM Cy5 azide dye (Cyandye), and 100 mM ascorbic
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acid (MilliporeSigma) for 30 min at room temperature. Samples were thoroughly
washed, and then underwent immunostaining as described above.
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High curvature dilutes the nuclear lamina
and favors nuclear envelope rupture,
especially for rapid distension
In Chapter 3, we showed that migration through constrictions, as occurs in vivo during
processes such as tumor growth and metastasis, ruptures nuclei. In this chapter,
we show that rupture consistently associates with high curvature—whether imposed
by pores or pipettes—and with nuclear entry of chromatin-binding cGAS (cyclicGMP-AMP-synthase) from cytoplasm. Suppression of lamin-A, a main component of
the nuclear lamina, has been seen to increase rupture during constricted migration
(Irianto et al. 2016a), but the dynamics of lamin proteins under high curvature,
and the mechanism by which lamin-A protects against rupture, remain incompletely
understood. Thus, we studied the effect of curvature on lamina organization and
nuclear rupture by passively pulling detached cells into micropipettes under controlled
pressure. A549 human lung carcinoma cells with gene-edited RFP-lamin-B were
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transfected with lamin-A-GFP, detached and latrunculin-treated, and then aspirated
at various rates into small-diameter pipettes. Extension of a nucleus into a micropipette
caused dilution of lamin-B at the leading tip of the nucleus, proportional to aspirated
length L, whereas dilution of lamin-A occurred only for L > Lcritical at the same
early timepoint in aspiration. Lamin-A thus requires a critical strain to flow, and,
importantly, nuclear rupture also occurs at or above this critical dilution in lamin-A.
Similar studies were done with siLMNA U2OS human osteosarcoma cells that express
low or high levels of lamin-A-GFP (∼10-fold range), with low levels of lamin-A indeed
showing greater lamin-A dilution and more nuclear rupture versus high levels. These
results hint that lamin-A protects against rupture by behaving as a rigid body at
low strains; at higher strains, lamin-A behaves as a viscous fluid, which allows it
to flow into lamina holes after nuclear rupture.

4.1

Introduction

Nuclear rupture and excess γH2AX have been reported for hypercontractile cancer
cells in standard culture conditions (Takaki et al. 2017) and for cardiac cells in intact
embryonic hearts subjected to a sudden spike in contractility (Cho et al. 2019). Sources
of damage remain unclear and potentially include membrane-permeable reactive oxygen
species, but cytoplasmic nucleases have also been speculated to enter ruptured nuclei
(Denais et al. 2016; Raab et al. 2016). Nuclear blebs that form at rupture sites
accumulate cyclic GMP-AMP synthase (cGAS), which enters from cytoplasm and
which could in principle bind γH2AX to inhibit repair in the bleb (Liu et al. 2018a).
However, such blebs show no excess γH2AX, which tentatively argues against nuclease
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entry (Irianto et al. 2017). DNA repair factors clearly mislocalize to cytoplasm for
hours, as shown in Chapter 3, but it remains uncertain whether any DNA damage
relates to nuclear depletion of such factors if not nuclear entry of nucleases or other
factors. Similar questions apply to micronuclei that form in mitosis with missegregated
chromosomes (independently of actomyosin) and that somehow exhibit DNA damage
as well as depletion of lamin-B and DNA repair factors (Hatch et al. 2013; Liu et al.
2018b). Because lamin filaments are stiff (Turgay et al. 2017), the frequent observation
of lamin-B loss from curved regions of nuclear membrane might seem physically sensible,
but effects of deformation rate, chromatin stress, and nuclear envelope tension are
equally conceivable. In this chapter, we ultimately relate rupture and dysregulation of
the DNA damage response to curvature and rate rather than tension.

4.2

Results and discussion

Micropipettes allow controlled pressures to be applied to detached cells over hour-long
timescales, as is relevant to pore migration, and the ∼kPa pressures are relevant to
the traction stresses applied by cells to 2D gels (Harada et al. 2014; Wolf et al. 2009).
To understand the behavior of the endogenous B-type lamins that are disrupted in
migration, A549 cells with gene-edited RFP-lamin-B1 were studied. Depletion of this
lamin on the protruding tip of the nucleus increases with time (Fig. 4.1A) and steepens
with decreasing pipette diameter Dp (Fig. 4.1B). Higher curvature imposed by smaller
pores thus causes greater dilution of the lamina, which is consistent with nuclear blebs
and rupture occurring only after migration though highly constricting pores. It is also
consistent with theoretical predictions based on the time-dependent redistribution of
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Figure 4.1: A549 cells with endogenously RFP-tagged lamin-B1 were pulled into a ∼3
µm pipette under controlled pressure after latrunculin treatment and detachment. (A)
In all cells, lamin-B shows initial depletion from the leading tip of the nucleus, which is
quantified as a decline in the tip-to-outside RFP-LMNB1 intensity ratio (inset) over an
∼hour-long aspiration experiment. Each cell is represented by a different symbol and fit
with a blue line. The red dashed line is fit to all data (8 cells). (B) The blue-line slopes
from A are binned and plotted against pipette diameter; the exponential decay is a guide to
the eye and indicates little effect beyond ∼5 µm (error bars = SEM). (C) A representative
A549 RFP-LMNB1 cell with overexpressed GFP-53BP1 squeezes into a micropipette. The
aspirated nucleus shows lamin-B dilution at the leading tip and rupture of GFP-53BP1 into
the cytoplasm. Notably, the nucleus also shows segregation of GFP-53BP1, a mobile protein,
away from regions of high chromatin compaction. These local density gradients are evident
before aspiration (inset), and then exacerbated by applied pressure, especially at the pipette
entrance (representative of 4 cells, n = 2 experiments).
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lamin-B as a consequence of nuclear deformation under applied pressure (Fig. C.1,
“Theoretical model for curvature-driven dilational flow of lamin-B” in Appendix C).
Even before pressure is applied, the nucleoplasmic repair factor GFP-53BP1 shows
a density distribution anti-correlated with DNA (Fig. 4.1C, grayscale insets); the
anti-correlation becomes even more apparent upon aspiration, with DNA entering
the micropipette and becoming more dense while 53BP1 is excluded. Leakage of
53BP1 from the tip is also evident (Fig. 4.1C).

4.2.1

High curvature drives nuclear envelope rupture during
constricted migration

Given the dependence of lamin-B dilution on pipette size, we next quantified the
pore size dependence of nuclear envelope rupture, which we hypothesize is key to the
excess DNA damage incurred during constricted migration (Fig. 3.1C, 3.2, 3.3A).
U2OS cell migration through custom-etched transwell membranes (Fig. C.2) reveals
that rupture frequency is a sigmoidal function of pore curvature, calculated as the
inverse of pore diameter (Fig. 4.2A, blue curve). Smaller pores, which impose greater
curvature on migrating cells, cause higher rates of nuclear envelope rupture. To assess
whether such rupture reflects the intrinsic limits of nuclear strength or stability, U2OS
cells were detached, latrunculin-treated, and aspirated into micropipettes of varying
diameter Dp under a wide range of pressures. Monitoring of nuclear cGAS entry as an
indicator of nuclear envelope rupture reveals again a sigmoidal relationship between
rupture frequency and curvature (Fig. 4.2A, red curve). Surprisingly, some of the
highest tensions (calculated as ∼aspiration pressure × pipette circumference) do not
consistently cause nuclear rupture; instead, rupture frequency correlates best with
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Figure 4.2: (Previous page.) (A) Detached latrunculin-treated U2OS cells transfected with
mCherry-cGAS and GFP-lamin-B1 were pulled under controlled pressure into micropipettes
of varying diam., Dp . The probability of nuclear rupture—as indicated by nuclear entry
of mCherry-cGAS, a cytoplasmic DNA binding protein—increases with 1/Dp (we ignore a
factor of 2 in the conventional definition of curvature). Rupture probability shows the same
functional dependence on curvature for active migration through transwell pores, where
rupture is indicated by nuclear bleb formation. Fit function and parameters are per the
single filament model described in Section 4.2.2; also, y = Axm /(B + xm ) fits equally well
with m = 4, consistent with a continuum model (Appendix C.1; ≥6 cells per Dp ; ≥50 cells
per transwell pore diam.; error bars = SEM). Inset: Derivatives of fits indicate a critical
pipette/pore diam. of ∼4 µm. (B) Smaller pores increase nuclear bleb size and lamin-B
dilution (i.e. nucleus-to-bleb lamin-B intensity ratio minus 1). Dashed line is fit to first
two points and the origin (≥11 cells per transwell pore diam.; error bars = SEM). Images:
nuclear blebs indicated by arrows. Scale bars = 10 µm. (C) Accumulation of mCherry-cGAS
at the aspirated tip of the nucleus (arrow) indicates nuclear rupture, which coincides with
GFP-LMNB1 dilution. (D) Tip dilution of lamin-B1 (α) is relative to inside intensity (inset),
and mCherry-cGAS accumulation is normalized (norm.) to both cytoplasmic intensity and
pipette cross-section (as a maximum area). Binned points show that higher α correlates with
more cGAS inside the nucleus at t ≈ 5 min. Each point is labeled with the mean pipette
diameter for cells within that bin (36 cells total, ≥5 cells per bin; error bars = SEM). (E)
(i) For every aspirated cell at t ≈ 15 sec, nuclear extension ∆L into the pipette shows that
low or slow ∆L associates with low α (unshaded region), and small diameter (2-4 µm) is
needed for high α (shaded region). Filled portions of data points indicate the fraction of
nuclei within each bin that rupture by t ≈ 5 min, with upper heatmap indicating rupture
probabilities (Prob.) for low or high ∆L (36 cells total, ≥3 cells per bin; error bars = SEM).
(ii) Cells aspirated into a pipette of critical diam. Dp = 4 µm were binned as ruptured or
not, and α and ∆L/t were measured for each cell at t ≈ 1 sec (light red), and then again
at a set extension of ∆L = 10 µm (dark red). Fast nuclear entry (bin average aspiration
pressure: ∆P = 4.6 ± 1.2 kPa) corresponds to more severe lamin-B1 dilution—and thus
more rupture—than slow entry (∆P = 3.2 ± 1.0 kPa) even for constant extension (6 cells
total, 3 cells per bin; error bars = SEM). (F) Lamin-B filaments are too stiff to bend along
high-curvature nuclear membranes—and are thus depleted—but can stably interact with
low-curvature membranes.

curvature and with pressure (Fig. C.3A-C.3D). Importantly, the smallest curvatures
cause nuclear rupture even at the lowest pressures and rates.
The curvature dependence of nuclear envelope rupture fits a statistical physics
model of a single filament attached to or detached from a curved surface, as follows.
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We consider a single lamin-B filament that is stiff with a measurable length Lf il and
persistence length `p (Turgay et al. 2017). Because the filament can be either attached
to or detached from the nuclear membrane, it is described by the partition function
Z=

X

e−Es /kB T = e−Eattached /kB T + e−Edetached /kB T .

(4.1)

s

We choose the detached state as the reference state with Edetached = 0. The energy of
the attached state results from the competition between two energy terms:
Eattached = Ebinding + Ebending ,

(4.2)

where Ebinding and Ebending are, respectively, a negative binding energy that favors
filament attachment and a positive bending energy due to curvature distortion imposed
by the nuclear membrane.


Expanding Ebending in curvature

1
D



yields

Eattached = −E +
where

a
k
+ 2,
D D

(4.3)

a
captures the contact area between the nuclear membrane and the lamin-B
D

filament ([a] = [E] × [L]), and the last term is simply a bending energy with filament
bending modulus k = (`p kB T )Lf il ([k] = [E] × [L2 ]). These expansion terms increase
(i.e. become more positive) for higher membrane curvature, which opposes filament
adsorption. The probability of the detached state is then
Pdetached =
Pdetached =

1 −Edetached /kB T
e
Z
1

1+

e(E−a/D−k/D2 )/kB T
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In the high-curvature limit,
e(E−a/D−k/D

2 )/k

BT

a
and the bending term become very large such that
D

 1 and Pdetached → 1, consistent with high probability of lamin-B

loss and nuclear envelope rupture in high-curvature transwell pores and micropipettes
(Fig. 4.2A). In the low-curvature limit,

1
→ 0, Pdetached → 1/(1 + eE/kB T ) → 0,
D

assuming E  kB T , which is consistent with strong attachment.
When fitting the curvature dependence of nuclear envelope rupture in transwell
pores and micropipettes (Fig. 4.2A), we use the values `p = 0.5 µm and Lf il = 0.38
µm from Turgay et al. (2017) to set the bending modulus k in the quadratic term:
k = (`p kB T )Lf il = (0.5 µm)(0.38 µm)kB T = (0.19 µm2 )kB T . The ratio between
the interaction energy a and the binding energy E provides a critical length scale
that corresponds to the inflection point of the rupture-versus-curvature plot (Fig.
4.2A). Pore/pipette diameters smaller than a/E are in the high-curvature regime
and favor lamin-B desorption; diameters larger than a/E are in the low-curvature
regime that favors lamin-B attachment. To note, the curvature dependence of nuclear
rupture also conforms to a continuum model of lamina bending with a curvature4
dependence for lamina dilution (Appendix C.1).
Lamin-B dilution on blebs after transwell migration also depends on pore curvature
(Fig. 4.2B). The size of the major bleb (ignoring second blebs and blebless scars of
disrupted lamin-B) increases with dilution—most dramatically for pore diameters
of 3-5 µm. The 3-5 µm size range corresponds well with the curvature-dependent
peak for rupture (Fig. 4.2A, inset). Dilution at the tip of the aspirated nucleus was
similarly quantified with GFP-lamin-B1 (Fig. 4.2C, 4.2D) and with the nuclear pore
factor GFP-Nup153 (Fig. C.3E), and both tend to dilute more at higher curvature.
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Lamin-B1 dilution was already reported in Fig. 4.1, but here we clearly see that
this dilution correlates spatiotemporally with loss of nuclear envelope integrity, based
on accumulation of mCherry-cGAS at the aspirated tip. High curvature thus favors
lamin-B1 disruption and nuclear rupture in both Transwell pores and micropipettes.
For every aspirated cell, the extension of the nucleus into the pipette was measured
at an early time point (t = 15 sec out of a total aspiration time of ∼5 min). Across all
pipette diameters, low extension leads to minimal lamin-B1 dilution (Fig. 4.2E-i; Fig.
C.3F), suggesting slow entry always limits lamina disruption. In small pipettes (2-4
µm), lamin-B1 dilution increases sharply with extension and extension rate, whereas
in large pipettes (6 or 8 µm), lamin-B1 dilution remains low (Fig. 4.2E-i) except
at very high extension rates (Fig. C.3F-ii). To assess whether nuclear extension or
nuclear extension rate determines nuclear rupture, data for the critical pipette size Dp
= 4 µm was plotted separately for rupture (high pressure) or no rupture (low pressure)
at an initial time point and at 10 µm extension, which corresponds to the thickness
of a transwell (Fig. 4.2E-ii). Rupture clearly associates with larger lamin-B dilution
and higher extension rates. Importantly, the lack of rupture at low rates of aspiration
can explain why myosin-II inhibition in constricted migration through similarly-sized
pores, which dramatically reduces migration rate, also effectively eliminates nuclear
envelope rupture (Xia et al. 2019).
Lamin-B filaments have high affinity for the nuclear envelope (because of farnesylation and lamin-B receptor) but are stiff with a persistence length of ∼0.5 µm or larger
measured for lamins in mouse cells (Turgay et al. 2017). Such filaments will tend
to dissociate from a nuclear envelope of high Gaussian curvature. We hypothesize
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that lamin-B filaments are therefore depleted from high-curvature regions but stably
interact with low-curvature regions (Fig. 4.2F). This physical picture applies most
clearly to the leading tip of the nucleus pulled passively into micropipettes or during
cell migration through transwell pores of varying diameter. It could also apply to
other instances of diverse membrane curvature, such as micronuclei of varying size.

4.2.2

Beyond a critical strain, lamin-A dilutes and nuclei
rupture at sites of high curvature

Detachment of stiff lamin-B filaments from high-curvature regions of the nuclear
envelope might account for the characteristic absence of lamin-B from nuclear blebs
after constricted migration. But whereas lamin-B is depleted from the bleb, lamin-A
is typically present and often enriched there. We wondered whether this contrast
might reflect differences in the mechanical properties of the two lamin sub-types;
previous studies have suggested that lamin-A and lamin-B contribute viscous and
elastic stiffness, respectively, to the nucleus (4.3A, Swift et al. (2013)). To study the
mechanics of lamins-A and -B, we transfected gene-edited RFP-LMNB1 cells with
lamin-A-GFP, and then pulled the detached cells at varying rates (∼5-fold range)
into micropipettes of diameter Dp ≈ 3.5 µm (Fig. 4.3B). Following our observations
of lamin-B loss at the leading tip of aspirated nuclei, we measured tip dilution α of
RFP-LMNB1 and LMNA-GFP relative to inside intensity, as described above and
elaborated in Section 4.3. For both lamin-A and lamin-B, α increases with nuclear
entry rate, meaning more severe lamina disruption for faster cell migration. However,
whereas proportional lamin-B dilution is observed even at very low extension (rate),
lamin-A dilution is observed only above a threshold (rate of) extension into the pipette
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Figure 4.3: Lamin-A requires a critical strain to flow. (Continued next page.)
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Figure 4.3: (Previous page.) (A) A-type and B-type lamins assemble with distinct
membrane-binding partners into juxtaposed networks just inside the inner nuclear membrane.
Previous studies suggest that lamin-A confers viscous stiffness to nuclei, while lamin-B
contributes to nuclear elasticity (Swift et al. 2013). We hypothesize that high curvature that
is rapidly imposed by pores or pipettes will cause near-instantaneous dilution of lamin-B,
whereas dilution of lamin-A will be time- or rate-dependent, consistent with lamin-A’s
proposed viscous properties. (B) A549 cells with gene-edited RFP-lamin-B were transfected
with lamin-A-GFP, detached and latrunculin-treated, and then aspirated at various rates
into pipettes of diam. Dp ≈ 3.5 µm. (C) Extension of a nucleus into a micropipette causes
dilution of lamin-B at the leading tip of the nucleus, proportional to aspirated length ∆L,
whereas dilution of lamin-A occurs only for ∆L > ∆Lcritical at the same early timepoint
in aspiration. Dilution (α) calculated as described in Fig. 4.2 and Sec. 4.3 (n = 14 cells;
1-4 cells per bin; points are mean ± SEM for each bin). (D) Nuclear entry rate into a
micropipette correlated poorly with aspiration pressure at early (black) and later (gray)
timepoints (n = 14 cells).

(Fig. 4.3C, C.4). Lamin-A thus requires a critical strain to flow. In this experiment,
rates of nuclear extension into the pipette correlated poorly with applied pressures
(Fig. 4.3D), which improves confidence that lamina dilution is primarily a consequence
of rapidly imposed high curvature rather than rapidly applied high pressure.
Lamin-A knockdown is known to render nuclei more prone to rupture during
micropipette aspiration (Chapter 5, Irianto et al. (2016a)), under AFM tips (Xia et al.
2018), and even in 2D culture on rigid substrates (Tamiello et al. 2013; Xia et al.
2018). The finding that lamin-A flows like lava beyond a critical strain, ∆Lcritical ,
begins to suggest that lamin-A protects against rupture by behaving as a rigid body
at low strains. At higher strains, lamin-A behaves as a viscous fluid, which allows it to
flow into lamina holes after nuclear rupture—hence, enrichment of lamin-A on many
nuclear blebs. To directly test the effect of lamin-A levels on lamin-A flow and nuclear
rupture, U2OS cells were transfected with (i) siRNA against lamin-A to produce
knockdown of endogenous protein, and then (ii) LMNA-GFP to yield a ∼10-fold range
77

4. High curvature dilutes the nuclear lamina and favors nuclear envelope rupture,
especially for rapid distension

B

High LMNA

103

L/t (µm/s) at t = 10 s

A

LMNA-GFP pre-aspiration
intensity norm.

Figure 4
High
Med-high

Low LMNA
Med-low
Low

102

102

Low LMNA

1.0

Med-high

High

0

104

0

10

LMNA-GFP pre-aspiration intensity
(2 ms exposure time)

P=

Slow entry
~1.8 kPa

0s

(ii) High LMNA-GFP
Slow entry
~2.1 kPa

Fast entry
~4.9 kPa

~ 8 min

0s

0s

~ 2 min

Fast entry
~11.7 kPa

~ 8 min

0s

~ 8 min

DNA

LMNA
-GFP

mCherrycGAS

Pressure (kPa)

(i) Low LMNA-GFP

C

LMNAGFP

Med-low

5 m

E (i)

cGAS+
cGAS-

2

0

% ruptured at t = 4 min

at t = 10 s

D

Chromatin herniation
Low LMNA:
y = 4.03 (logx - log(0.44))
R2 = 0.80
High LMNA:
y = 1.85 (logx - log(0.44))
R2 = 0.94

2

10

0.2

1.0

L (µm)

(ii)
Low LMNA
High LMNA

80

40

0

0

1.0

at t = 4 min

0

1.0

L/t (µm/s) at t = 10 s

L/t (µm/s)

@ t = 10 s

Figure 4.4: Suppression of lamin-A increases lamina dilution and nuclear rupture.
(Continued next page.)

78

4. High curvature dilutes the nuclear lamina and favors nuclear envelope rupture,
especially for rapid distension
Figure 4.4: (Previous page.) (A) siLMNA U2OS cells were transfected with LMNAGFP and mCherry-cGAS, and then detached and latrunculin-treated in preparation for
micropipette aspiration. Cells had a wide range of initial LMNA-GFP intensities, as measured
by two different but highly correlated metrics: intensity norm. to optimized exposure time
(=20-600 ms) and intensity at a set exposure time of 2 ms (n = 18 cells). (B) Cells were
pulled under varying pressure into pipettes of diam. Dp ≈ 3.5 µm, and extension ∆L of
each nucleus into the pipette was measured at t ≈ 10 s. Binned points (±SEM) show that
low-lamin-A cells are more compliant than high-lamin-A cells, with greater nuclear extension
at a given aspiration pressure (n = 18 cells; 1-4 cells per bin). (C) As seen in representative
images, low levels of lamin-A cause greater lamin-A dilution at the leading tip of the nucleus
versus high levels. Low lamin-A also causes more nuclear envelope rupture, as indicated
by nuclear cGAS entry (white arrows) and chromatin herniation (yellow arrowheads). (D)
Analysis confirms that low-lamin-A cells show greater lamin-A dilution α and more nuclear
rupture as compared to high-lamin-A cells. Solid lines are fits to the 11 low-lamin-A cells
and the four high-lamin-A cells with the highest ∆L(/t) at t = 10 s; dashed lines are meant
to guide the eye (n = 18 cells). (E) % ruptured comprises cGAS+ cells and/or cells with
chromatin herniation (n = 18 cells; error bars = SEM).

in overall lamin-A expression (Fig. 4.4A, C.5A). A 10-fold range is much greater than
the natural variation in lamin-A levels among wild-type U2OS cells but comparable
to the difference in lamin-A levels between wild-type and siLMNA cells (Fig. C.5B).
These siLMNA +LMNA-GFP cells were detached, treated with latrunculin, and
aspirated into ∼3.5 µm-diameter pipettes, where low-lamin-A cells proved to be more
compliant, as expected, than high-lamin-A cells (Fig. 4.4B). Low-lamin-A cells also
exhibit more severe dilution of lamin-A at the leading tip of the nucleus, accompanied
by higher frequency of nuclear rupture based on nuclear accumulation of cGAS as
well as chromatin herniation (Fig. 4.4C - 4.4E-i, C.5C-C.5D). And while all cells show
the expected correlation between rupture frequency and rate of nuclear extension into
the pipette, low-lamin-A cells rupture at comparatively lower extension rates (Fig.
4.4E-ii). Importantly, regardless of expression level, lamin-A requires a critical strain
to flow in U2OS cells just as it does in A549 cells (Fig. 4.4D, 4.3C).
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Figure 4.5: Nuclear shape fluctuations produce regions of high curvature, where lamin-B
but not lamin-A is diluted. (A) Histograms show that on Top of a transwell membrane,
a “spindle-shaped” A549 clone has a significantly higher average nuclear aspect ratio than
wild-type (WT) A549 cells. Migration to the Bottom (‘Bot’) of the transwell membrane—
where cells have room to spread—causes an increase in WT nuclear aspect ratio, though it
remains (non-significantly) lower than spindle-shaped nuclear aspect ratio for both 3 and 8
µm pores (≥111 cells per condition). (B) The ratio of lamin-B-to-lamin-A intensity at the
poles of a spindle-shaped A549 nucleus decreases with aspect ratio, suggesting that high
curvature imposed by cytoskeletal forces in 2D culture is sufficient to dilute lamin-B but not
lamin-A. Gray points are fixed, immunostained cells from 3 µm Bot, while the line is fit to
binned data (black points) (n = 48 cells, error bars = SEM).

Micropipette aspiration occurs at a faster rate and under greater external pressure
than migration through transwell pores or 3D tissue; ∆L  ∆Lcritical is difficult to
probe with this technique. Therefore, we sought to examine lamina organization in a
system where changes in curvature occur at a slow rate and without external pressure.
We took advantage of an A549 clone with an elongated shape, similar to that of the
U2OS clone described in Chapter 3. Because of its high nuclear aspect ratio in 2D
culture (Fig. 4.5A), the spindle-shaped A549 clone gives us a way to study high nuclear
curvature that is imposed slowly (∼tens of minutes (Xia et al. 2018)) by cytoskeletal
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forces, rather than rapidly (∼seconds) by aspiration pressure. We measured the ratio
of lamin-B-to-lamin-A intensity at the poles of fixed, immunostained spindle-shaped
A549 nuclei. Nuclei that are highly elongated show significant polar depletion of laminB relative to lamin-A (Fig. 4.5B), consistent with the idea that stiff elastic lamin-B
responds instantaneously to applied stress, while viscous lamin-A responds only above
some threshold strain or strain rate (that is not attained by cytoskeleton-mediated
changes in nuclear shape). Much more study of these spindle-shaped A549 cells is
needed. For example, it will be important to determine the timescale of the shape
fluctuations that produce regions of high curvature in spindle-shaped A549 nuclei.

4.3

Materials and methods

Cell culture

U2OS human osteosarcoma cells were cultured in DMEM high-glucose

medium (Gibco, Life Technologies), supplemented with 10% fetal bovine serum (FBS;
MilliporeSigma) and 1% penicillin/streptomycin (MilliporeSigma). A549 human lung
cancer epithelial cells were cultured in supplemented Ham’s F12 medium (Gibco,
Life Technologies). A549 cells with endogenously GFP-tagged CTNNB1 and RFPtagged LMNB1 were purchased from MilliporeSigma. The A549 spindle-shaped
clone was generated by subjecting wild-type clonal A549 cells to several consecutive
rounds of mitosis under confinement.
Transfection

GFP-53BP1 and mCherry-cGAS were gifts from Dr. Roger Greenberg

(University of Pennsylvania, Philadelphia, PA) (Harding et al. 2017). LMNA-GFP was
a gift from Dr. David Gilbert (Florida State University, Tallahassee, FL) (Izumi et al.
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2000). We used small interfering RNAs (siRNAs) purchased from Dharmacon (ONTARGETplus SMARTpool siLMNA, L-004978-00; and non-targeting siRNA, D-00181010). We transfected either siLMNA (25 nM) or GFP/mCherry (0.5 ng/mL) with 1
µg/mL Lipofectamine 2000 (Invitrogen, Life Technologies) for 72 hours (siLMNA)
or 24 hours (GFP/mCherry) in corresponding media, supplemented with 10% FBS.
Knockdown efficiency of siLMNA was determined by immunofluorescence microscopy
and by western blot via standard methods.
Micropipette aspiration

Prior to aspiration, cells were first detached using

0.05% Trypsin-EDTA (Gibco, Life Technologies), and then incubated in 0.2 µg/mL
latrunculin-A (MilliporeSigma) and 8 µM Hoechst 33342 (Thermo Fisher) for 30
minutes at 37◦ C, as described previously (Pajerowski et al. 2007). Finally, cells
were re-suspended in PBS with 1% BSA and 0.2 µg/mL latrunculin-A. Aspiration
experiments were imaged using a Nikon TE300 epifluorescence microscope—with
a 60×/1.25 NA oil-immersion objective—and a digital EMCCD camera (Cascade,
Photometrics). Images were later quantified in ImageJ (Schneider et al. 2012).
Transwell pore etching

Porous membrane cell culture inserts are commercially

available from Corning; they come in a limited assortment of pore diameters, including
1, 3, 5, and 8 µm. To generate intermediate pore sizes, such as 4 or 6 µm, the
polycarbonate membranes were etched with 2 M NaOH in a 60◦ C incubator. 3 µm pore
membranes were incubated for 72 min and 120 min to generate 4 and 5 µm-diameter
pores, respectively. The same conditions were used to etch 5 µm pore membranes to
generate 6 and 7 µm-diameter pores. To achieve pores of <3 µm diameter, 1 µm pore
membranes were irradiated with 365 nm ultraviolet light (Spectroline XX-15A, 0.7 A)
82

4. High curvature dilutes the nuclear lamina and favors nuclear envelope rupture,
especially for rapid distension
for 30 min per side, and then etched with 9 M NaOH at room temperature (22◦ C).
Etching for 4.5 and 5 h yielded 2.2 and 2.3 µm-diameter pores, respectively. In every
case, after etching, membranes were thoroughly washed with MilliQ water and dried
under vacuum. Etched membranes were sterilized with UV irradiation before being
used in migration assays. Etching conditions were adapted from Cornelius et al. (2007).
The sizes of etched pores imaged by confocal microscopy were measured/confirmed by
ImageJ (Schneider et al. (2012); Fig. C.2). Expected etched pore sizes matched well
with measured pore sizes. Additionally, etched 4 and 5 µm pores, for instance, have
the same distributions as the commercially available 3 µm ones and are sufficiently
tight that the 4 µm pore is not a combination of 3 and 5 µm pores.
Transwell migration Migration assays were performed using commercially available
transwell polycarbonate membranes with pore diameters of 3, 5, and 8 µm as well
as etched membranes (see above) with modified pore diameters of 4, 5, 6, and 7 µm.
Detached U2OS cells were seeded on top of each membrane at a density of 4.5 × 105
cells/cm2 ; supplemented medium was added to the top and bottom of the membrane
such that there was no nutrient gradient. Cells were allowed to migrate to the bottom
over the course of 24 hours at 37◦ C and 5% CO2 . Finally, membranes—with unmigrated cells attached on top and migrated cells attached on the bottom—were
formaldehyde-fixed and stained as described below.
Immunostaining and imaging

Cells were fixed in 4% formaldehyde (Millipore-

Sigma) for 15 minutes, and then permeabilized by 0.25% Triton-X (MilliporeSigma)
for 10 minutes. After 30-minute blocking by 5% bovine serum albumin (BSA;
MilliporeSigma), cells were incubated in primary antibodies overnight at 4◦ C. The
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antibodies used include anti-lamin-A/C (Cell Signaling) and anti-lamin-B1 (Abcam).
Finally, following 90-minute incubation in secondary antibodies (Thermo Fisher), cells
were stained with 8 µM Hoechst 33342 (Thermo Fisher) for 15 minutes, and then
mounted on #1.5 coverslips using Prolong Gold antifade reagent (Invitrogen, Life
Technologies). Unless otherwise specified, steps were carried out at room temperature.
Confocal imaging of cells was done on a Leica TCS SP8 system with a 63×/1.4
NA oil-immersion objective. Scanning electron microscopy (SEM) of commercially
available and etched Transwell membranes was performed with an FEI Quanta 600
FEG Mark II ESEM, operated in wet environmental mode. Images were quantified
in ImageJ (Schneider et al. 2012).
Calculating lamin-A or lamin-B dilution

To quantify lamin(-A or -B) dilution

on a nuclear bleb, we measure the average background-subtracted lamin intensities of
the entire on-bleb and off-bleb regions of a blebbed nucleus. Lamin dilution is then
the ratio of the off-bleb intensity to the on-bleb intensity—minus 1 so that dilution
= 0 if the bleb exhibits zero lamin deficiency. Lamin dilution at the leading tip of
an aspirated nucleus is calculated similarly, except on-bleb and off-bleb intensities
are replaced by tip and ‘inside’ intensities (Fig. 4.2D, inset), which are measured
within boxes of area ≈ pipette diameter2 . Dilution of nuclear pore complex proteins
(GFP-Nup153) is calculated in the same way (Fig. C.3E).
Identification of nuclear blebs

Nuclear blebs are characterized by enrichment of

lamin-A and near absence of lamin-B. To detect blebs in a given confocal projection,
lamin-A fluorescence signal (red) is superimposed over lamin-B fluorescence signal
(green) such that nuclear regions of high-lamin-A/low-lamin-B (i.e. high-red/low-green)
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are easily detected by eye (Fig. 4.2B). Many blebs present as irregular protrusions from
the nucleus and are thus highly conspicuous; others present as subtler ‘scars’ in the
nuclear body (Fig. 1.2). Nuclei are classified as either bleb-positive or bleb-negative,
and then the fraction of blebbed nuclei is calculated.
Nuclear indentation by atomic force microscopy (AFM) during fluorescent
imaging

U2OS cells transfected with mCherry-cGAS and siLMNA were replated

on coverslips at a density of 6×104 cells/cm2 and cultured overnight. Coverslips were
mounted in the fluid cell of a hybrid AFM system (MFP-3D-BIO, software: MFP3D+Igor Pro 6.05; Asylum Research, Oxford Instruments), which has a base plate
and X-Y scanner that rest on an inverted optical fluorescence microscope (Olympus
IX81 with 40×/0.60-NA objective). Experiments were performed in closed liquid cell
at temperature of ∼29◦ C in high-glucose DMEM with 10% serum and buffered at pH
7.4 with 25 mM Hepes to prevent cell death in the absence of CO2 (Frigault et al.
2009). Cells were indented using MSCT-AUHW cantilevers (Bruker) with nominal
spring constants 0.03-0.1 N/m, nominal tip radius 10-40 nm, and nominal tip height
2.5-8 µm. Before each experiment, cantilever spring constants were calibrated via the
thermal fluctuations method to determine indentation forces. Then, a fluorescent cell
was chosen for probing by AFM based on expression pattern; for example, expression
of mCherry in the cytoplasm. The cantilever was positioned on the top of the nucleus,
and the nucleus was locally compressed with forces of ∼10-40 nN. When the cantilever
deflection reached the predefined set point, the tip would dwell on the spot for a
predefined time of 100 s before the cantilever was retracted and detached from the cell.
Simultaneous fluorescent images were captured every 10 or 15 s for the entire probing
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cycle, including before force was applied and after the cantilever was retracted for
several minutes. In multiple independent experiments that cumulated to hundreds
of pokes on nuclei inside cells, mCherry-cGAS reliably ruptured into the nucleus. In
addition, poking over the nucleus rarely showed cytoplasmic rupture (∼1%), consistent
with nucleus-specific rupture. The same protocol was used and described in Xia et al.
(2018). The pressure that the tip exerted on the cell surface during typical maximum
indentation of ∼4 µm was estimated as P = F/(πa)2 , where F is the force and (πa)2
is the contact area between the tip and the cell for a given indentation.
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Nuclear constriction segregates mobile
nuclear proteins away from chromatin
As a cancer cell squeezes through adjacent tissue, penetrates a basement membrane,
or enters the smallest blood capillaries, its nucleus can be highly constricted, but any
effects on chromatin density and other nuclear factors are poorly understood. Here,
in cancer cell migration through rigid micropores and also in passive pulling into
micropipettes, local compaction of chromatin is observed coincident in space and time
with depletion of mobile factors. Hetero/eu-chromatin has been previously estimated
from molecular mobility measurements to occupy a volume fraction f roughly twothirds of the nucleus, but based on the relative intensity of DNA and histones in
several cancer cell lines drawn into narrow constrictions, f can easily increase locally
to nearly 100%. By contrast, mobile proteins in the nucleus, including a dozen that
function as DNA repair proteins (e.g. 53BP1) or nucleases (e.g. FokI), are seen to
exhibit a reduced density within the constriction to nearly 0%. Such loss of mobile
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nuclear factors—compounded by the occasional rupture of the nuclear envelope—has
important functional consequences for the cell. Constricted migration indeed delays
DNA cleavage by a FokI-lacR fusion of a target locus integrated into chromosome 1.

5.1

Introduction

As the largest and stiffest organelle (Dahl et al. 2008), the nucleus has long been
speculated to sterically limit a cell’s ability to migrate through small, stiff pores in
tissue matrix (Lichtman 1970). In migration through 3D fibrous matrix, the nucleus
has recently been described as a “piston” (Petrie et al. 2014) even though pistons tend
to be rigid. Softening the nucleus by lamin-A knockdown indeed enhances the rate
of cell migration through small constrictions for normal human primary cells as well
as cancer lines (Harada et al. 2014; Shin et al. 2013). In studying 3D migration, it
therefore makes sense to focus on the nucleus—in particular, how its extreme distortion
during transit impacts chromatin organization and nuclear factors.
Constricted migration of dendritic cells and of some cancer lines has been recently
reported to cause nuclear envelope rupture, exchange of nucleo-cytoplasmic proteins,
and an increase in GFP-53BP1 foci suggestive of DNA damage (Denais et al. 2016;
Raab et al. 2016). Loss of 53BP1, which can delay DNA repair, occurs across
many cancers of different tissue and cell types—more consistently than either the
activation of the repair kinase ATM or appearance of the phosphorylated-histone
marker of double-strand breaks γH2AX, and such loss of 53BP1 typically occurs
early in carcinogenesis (Nuciforo et al. 2007; Ward et al. 2003). However, the recent
study of cancer lines shows that ∼20% of migrating cells exhibit new GFP-53BP1 foci
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absent nuclear rupture (Denais et al. 2016), which means that rupture does not always
explain migration-induced foci. In this chapter, we show that rupture-free squeeze-out
of mobile nuclear proteins from a chromatin-rich constriction always occurs within
the nucleus, whereas rupture is less frequent. As a functional test, an inducible FokI
endonuclease model is used to show that protein squeeze-out—combined with protein
mis-localization during rupture—can inhibit nuclease-induced DNA damage, consistent
with calculations using an elastic nucleus model of constricted cell migration.

5.2
5.2.1

Results
Unavoidable segregation and occasional rupture

GFP-53BP1 is usually diffuse in the nucleoplasm, consistent with nucleoplasmic
mobility (Bekker-Jensen et al. 2005; Pryde et al. 2005). However, during hours-long
migration through a 3 µm transwell, as the nucleus contorts to enter or exit a pore,
GFP-53BP1 is less intense within the pore than either DNA or mCherry-histone
H2B, which are both enriched in the pore (Fig. 5.1A, 5.1B). Similarly, endogenous
53BP1 (immunostained) and the additional DNA repair factors GFP-KU70 and KU80 (Fig. D.1, 5.1B), all in the mobile phase (Table D.1), show less intensity within
the 3 µm pore than does chromatin, which is an immobile solid phase according to
FRAP (Pajerowski et al. 2007). Separation of mobile molecules from immobile ones
does not occur within 8 µm pores, as shown for a more homogeneously distributed
nuclear-localized construct (YFP-NLS in Fig. 5.1A, 5.1B) used also in Raab et al.
(2016). Interestingly, similar results are obtained regardless of exclusion from nucleoli
(53BP1 in Fig. 5.1A, D.1) or not (YFP-NLS in Fig. 5.1A). These observations
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Figure 5.1: Migration through small pores compacts the chromatin and causes local
depletion of mobile nuclear proteins plus occasional nuclear rupture. (Continued next page.)
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Figure 5.1: (Previous page.) (A) Schematics illustrate that as a cell nucleus squeezes into
a small pore, its chromatin becomes compact, while the opposite occurs with mobile proteins.
Confocal sections of fixed cells show the same as a nucleus squeezes into a 3 µm pore, with
mobile proteins such as GFP-53BP1 and YFP-NLS-MS2 decreasing in density within the
small pore (representative of ≥ 20 cells per protein). Pore exits show similar differences.
Large pores of 8 µm show no such differences in intensity. Intensity profiles for DNA and
protein are each normalized to the highest values along the dashed arrows shown in the
XZ slices (bar: 5 µm). (B) Segregation of mobile proteins, including endogenous 53BP1,
away from chromatin is evident at both the entrance and exit of 3 µm pores. Because
DNA is enriched inside the pore, its intensity ratio tends above 1; the same applies for
histone-H2B. Conversely, mobile proteins accumulate outside the pore, so their intensity
ratios fall consistently below 1. Segregation does not occur in 8 µm pores (≥20 cells per
group, n ≥ 3 expts). (C) Live imaging of H2B-mCherry-overexpressing U2OS cells reveals
nuclear rupture—with leakage of H2B into the cytoplasm—followed by nuclear re-localization
over hours (representative of n ≥ 3 expts). (D) At the top and bottom of a transwell
membrane, GFP-53BP1, -KU70, and -KU80 localize in the nucleus. For cells exiting 3 µm
pores, rupture is sometimes evident with mobile proteins in the cytoplasm based on GFP
proteins outside the boundary of lamin-B (red) and/or the DNA edge (blue) (≥9 exiting cells
per group, ≥100 top cells per group; *p < 0.05). The percentage of cells with mis-localized
GFP protein is likewise significantly greater for exiting cells than for cells that have fully
migrated to the bottom (≥35 bottom cells per group; *p < 0.05).

begin to suggest that chromatin is squeezed (like a sponge) as the nucleus is pulled
into a constriction, and this squeezing thereby excludes, and hence depletes, mobile
nucleoplasmic factors from the pore. Protein molecular weights vary by 6-fold, and
protein charges likely vary from highly anionic to weakly anionic as their isoelectric
points (pI) vary from pI ∼ 4.6 for 53BP1 to pI ∼ 5.8 for KU70 (Table D.1). In order to
assess the possible effects of local electrostatics, the level of acetylated histone H3 was
measured and found enriched within the 3 µm pores like DNA (Fig. D.2). In addition
to segregation within the nucleus of the mobile proteins, nuclei sometimes rupture
during transwell migration, causing H2B-mCherry, GFP-53BP1, and GFP-KU70 as
well as GFP-KU80 to leak at least for a few hours into the cytoplasm before ultimately
re-localizing in the nucleus (Fig. 5.1C, 5.1D).
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Micropipettes have a transwell-like, cylindrical pore geometry that is well suited
to visualizing nuclear mechanics within detached cells whose F-actin cytoskeletons
have been disassembled via latrunculin-A treatment (Pajerowski et al. 2007). Nuclear
factor segregation in this reductionist context was therefore examined. Aspiration of
many cells shows that GFP-53BP1 always segregates away from the chromatin that
condenses within the entrance of a small 3 µm micropipette (Fig. 5.2A). Notably,
segregation of the protein is evident from minute timescales to hour timescales,
as is relevant to migration through a transwell (Fig. 5.1C). These observations
begin to suggest a time- and motility-independent mechanism that segregates mobile
molecules away from immobile ones.
The various constructs used in the migration studies of Fig. 5.1 were imaged
in aspiration using smaller or larger micropipette diameters. GFP-53BP1, KU70,
and KU80 are all strongly excluded from small pipettes (Fig. 5.2B-i), and the
YFP-NLS construct is likewise excluded from 3 µm pipettes but not 8 µm pipettes
(Fig. 5.2B-ii). As with migration through pores, histone-H2B is also not excluded
from 3 µm pipettes (Fig. 5.2B-iii).
More than a dozen mobile nuclear proteins were expressed as GFP constructs
(Table D.1) and imaged during aspiration. Whereas DNA in all of these cells condensed
at the entrance for small pipettes (Fig. 5.2C-i), all mobile proteins indeed segregated
like GFP-53BP1, as quantified by the ratio of each protein’s intensity inside the
pipette entrance to its intensity outside the pipette (Fig. 5.2C-ii). Protein molecular
weights vary by 6-fold, and protein charges likely vary from highly anionic to cationic
as their isoelectric points (pI) vary from pI ∼ 4.6 for 53BP1 to pI ∼ 7.8 for dCas9
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(Table D.1). Upstream DNA damage response factors such as MRE11 and RPA1
(Hass et al. 2012), as well as downstream factors such as BRCA1 (Li and Yu 2013),
KU70, and KU80, all diminish within a ∼3 µm pore. The mobile proteins studied
also include a transcription factor (RelA), an epigenetic factor (Sirt6), and the gene
editing nuclease Cas9. Chromatin condensation near the entrance of the constriction—
as signified by the intensity ratios for histone H2B and heterochromatin protein
HP1α (Fig. 5.2D) in addition to DNA (Fig. 5.2C-i)—is also quantitatively similar
to that observed during transwell migration. Among all of the aspirated cells, 9095% exhibit this squeeze-out behavior with compressed DNA (Fig. D.3), and the
exceptions appear within statistical uncertainty of doing the same. Segregation is
thus an inevitable effect of nuclear squeezing.
Segregation is also highly sensitive to pipette diameter. Protein intensity ratios
decrease with decreasing pipette diameter. Importantly, the protein ratio decreases
to zero—signifying total squeeze-out—at an extrapolated critical diameter of ∼2 µm
(Fig. 5.2C). At that same critical diameter, the DNA intensity ratio should also
level off as the chromatin becomes maximally compacted inside the pipette; such a
plateau is indeed suggested by the increasingly shallow fit lines between statistically
significant DNA ratio data points. In the opposite limit, since both the DNA and
protein intensity ratios approach 1.0 above a threshold pipette diameter of ∼5 µm, the
DNA and protein flow almost equally into such large pores. It is unsurprising, then,
that transwell pores and pipettes with large diameters (∼8 µm) do not cause significant
condensation of DNA in the pore, nor do they induce segregation of YFP-NLS (Fig.
5.1A). The DNA and protein intensity ratios finally reach 1 at a diameter of ∼10 µm
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Figure 5.2: Mobile proteins segregate in micropipettes. (Continued next page.)
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Figure 5.2: (Previous page.) (A) U2OS cells overexpressing mobile GFP-53BP1 were
de-adhered and treated with latrunculin-A to depolymerize the actin cytoskeleton. When
the cell nucleus—inside the intact cell—is aspirated into a 3 µm-diameter pipette, chromatin
compacts and densifies at the pipette entrance whereas GFP-53BP1 depletes within the
pipette and sometimes even leaks out of the nucleus. Intensity profiles are shown along
the dashed arrows (representative of n ≥ 3 expts). (B) Segregation of other mobile GFP
proteins contrasts with a DNA-like profile for histone-H2B. (C) All other mobile proteins
studied—including repair, transcription, and epigenetic factors as well as a nuclease—also
segregate upon aspiration into ∼3 µm pipettes (≥3 cells per group). Segregation is sensitive
to pipette size: protein intensity ratio decays with decreasing diameter, vanishing at an
extrapolated critical diameter of ∼2 µm. Below this critical value, the DNA intensity ratio
plateaus as DNA reaches maximum compaction inside the pipette. Unfilled data points fall
between 3.0 µm and 3.7 µm in diameter; their average is indicated by a filled black square.
Solid gray lines are fits between filled points with statistically different intensity ratios,
whereas dotted gray lines are extrapolations or fits between points that are not statistically
different. YFP-MS2 was added after the fits but confirms expectations. Red dashed lines
show the intensity ratio limits for small and large pipette diameter. (D) Chromatin-bound
proteins do not segregate from DNA in ∼3 µm pipettes (≥4 cells per group). (E) A negative
linear correlation between protein intensity ratio and DNA intensity ratio is consistent with
chromatin occupying a solid volume fraction f of the nucleus while mobile proteins occupy
the free volume 1 - f (see “Image Analysis” in Sec. 5.4). Data from C were binned according
to average pipette diameter.

(Fig. 5.2C). Furthermore, these ratios exhibit the negative linear correlation that one
would expect given that chromatin occupies a solid volume fraction f of the nucleus,
while mobile proteins occupy the free volume 1 - f (Fig. 5.2E).
Whereas segregation always occurs within a constricted nucleus, large extension
into a 3 µm micropipette sometimes also gives rise to rupture like that of the segregated
GFP-53BP1 (Fig. 5.3A, 5.2A), which leaks over hours (Fig. 5.3B). Rupture and
loss of histone-H2B is 2- to 3-fold less likely than loss of the mobile factors (Fig.
5.3A), consistent with strong binding of H2B to DNA. For other cancer cell types, a
physically unavoidable steric exclusion mechanism would be expected to and indeed
does apply to GFP-53BP1 segregation and loss in rupture upon aspiration (Fig. 5.3C):
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mobile protein leaks steadily into the cytoplasm. The intensity of 53BP1 in the cytoplasm
and in the nucleus were measured over time. Reported is the percent of total 53BP1 found
outside the nucleus—that is, the cytoplasmic fraction—as a function of aspiration time. The
cytoplasmic fraction roughly doubles over the course of an hour. (C) Aspiration leads to
segregation and rupture of GFP-53BP1 in other cell types, as well: specifically, A549 human
lung cancer cells and EC4 mouse liver cancer cells (≥10 cells per group; n ≥ 3 expts). (D)
With lamin-A knockdown, lower pressure is required to induce nuclear rupture. During a
typical aspiration experiment, an initial low pressure (of ∼10 kPa) is applied to the nucleus
for a sustained period, after which the pressure is increased (to ∼50 kPa) if the nucleus
has not yet been fully aspirated. The stages are referred to as first and second aspiration,
respectively.
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these other cell types include the mouse liver cancer line EC4 as well as wild-type
and lamin-A knockdown A549 cells. The latter results hint at more rupture events
with low lamin-A, which prompted a careful examination of rupture as a function
of aspiration stress and time-course. That lower pressure is required for rupture of
lamin-A knockdown nuclei (Fig. 5.3D, consistent with Fig. 4.4) indicates a protective
role for lamin-A even on the timescale of minutes-long aspiration. Combined with
exclusion from the pore, these findings are all consistent with squeeze-out and overall
loss of mobile factors from the DNA compressed into the pore.

5.2.2

Nuclease inhibition by chromatin constriction

Loss of mobile factors during constricted migration should have functional consequences
for the cell, such as the delay of DNA damage by nucleases. To investigate this effect,
the U2OS sub-line was engineered to have on/off-inducible DNA damage in ∼200 sites
in one p-arm locus of chromosome 1 (Fig. 5.4A) (Shanbhag et al. 2010; Tang et al.
2013). Cleavage of this locus—by the mCherry-tagged FokI nuclease construct—is
induced by the addition of tamoxifen, which translocates the FokI construct into the
nucleus (through dimerization), along with Shield1, a stabilizing ligand that prevents
FokI degradation. Even in 2D culture, this damage induction produces the expected
correlations (i) between nuclease intensity and intensity of the phosphorylated-histone
marker of double-strand breaks γH2AX at the chromosome 1 locus, and (ii) between
the projected areas of the DNA damage response factor GFP-53BP1and γH2AX
at this large locus (DNA length is ∼600 µm). Note that whenever mCherry-FokI
is detectable as a focal spot, so are the repair factors. A standard electrophoretic
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Figure 5.4: FokI nuclease enacts on/off-inducible damage at a specially engineered locus
on chromosome 1 and also mis-localizes during migration. (Continued next page.)
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Figure 5.4: (Previous page.) (A) A lac operator transgene is integrated into the p-end of
chromosome 1 in the U2OS line. Expression of the integrated mCherry-Lac Repressor-FokI
construct can be stably induced with 4-OHT (Tamoxifen) and Shield-1 to create DNA breaks.
FokI intensity correlates with γH2AX intensity, while the area of GFP-53BP1 at the damaged
site is linearly correlated to γH2AX focus area. (B) A comet assay is sensitive enough to
detect induced DNA breaks: the mean centroid distance is higher for FokI-activated cells
(≥175 nuclei per group; n ≥ 3 expts). (C, D) Fluorescence recovery after photobleaching
(FRAP) shows that both nucleoplasmic and chromatin-bound mCherry-FokI are mobile,
with half-lives of 6 seconds and >2 minutes, respectively. The former is thus much more
mobile, and it indeed segregates outside a micropipette in D during aspiration (≥4 cells
per group; n ≥ 3 expts). (E) FokI nuclease is confirmed to segregate away from chromatin
during migration through 3 µm transwell pores (>10 cells per group; n ≥ 3 expts). (F)
Migration through 3 µm transwell pores also shows that FokI mis-localizes due to nuclear
rupture. Intensity profiles are shown along the dashed arrows (>10 cells per group; n ≥ 3
expts).

“comet assay” further shows that the controlled cleavage of DNA by the nuclease
produces a large and expected shift in the DNA centroid toward the cathode in the
majority of nuclei from 2D cultures (Fig. 5.4B).
Fluorescence recovery after photobleaching (FRAP) shows that nucleoplasmic
mCherry-FokI is highly mobile (Fig. 5.4C), with a half-life of around 6 seconds similar
to other constructs (Table D.1), whereas chromatin-bound FokI is also mobile but
with a significantly higher half-life of >2 minutes. The recovery of the chromatinbound FokI indicates an exchange between FokI comprising foci and the nucleoplasmic
FokI pool. Importantly, FokI is seen to segregate out of both micropipette and
transwell constrictions, diminishing within the pore by ∼50% in both cases (Fig.
5.4D, 5.4E). Rupture after transwell migration is also seen with a similar level of
mis-localization by ∼50% of FokI into the cytoplasm (Fig. 5.4F). The fact that
both segregation and mis-localization reduce the density of nucleoplasmic FokI per
total DNA by a similar amount could be a coincidence. Regardless, through both
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Figure 5.5: Constricted migration inhibits targeted FokI activity. (Continued next page.)

of these mechanisms, constricted migration should dampen FokI nuclease activity
on the specially engineered chromosome 1 locus.
Once FokI nuclease has been activated—by high (1 µM) tamoxifen and high
(1 µM) Shield1—to cleave the chromosome 1 locus, the percent of U2OS nuclei
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Figure 5.5: (Previous page.) (A - C) FokI cleavage of the engineered chromosome 1 locus
is induced at 0 hours by controlled addition of two components [tamoxifen, Shield1]. High
tamoxifen (1 µM, blue) yields a greater percent of cells positive for mCherry-FokI foci at
6 hours than either low (0.1 µM, gray) or zero (red) tamoxifen. In the absence of both
inducing chemicals (green), zero foci develop. For all three high-Shield1 groups (1 µM), the
percent of foci-positive cells decreases between 6 and 24 hours even as the nucleoplasmic
mCherry signal remains strong, indicating “burnout” of the LacO target site by the nuclease.
At 24 hours, the FokI construct is reactivated with high tamoxifen in all three high-Shield1
groups. Whereas the high-tamoxifen group continues to burn out as before, there are spikes
in FokI foci-positive cells for the low-tamoxifen and zero-tamoxifen groups. The burnout
rate between 6 and 24 hours is used to extrapolate the percent of FokI foci-positive cells at 0
hours, which is, in turn, used to calculate the change in the percent of foci-positive cells over
24 hours. This ∆% defined in B increases in magnitude with nuclear FokI intensity. Hence,
high tamoxifen (blue) leads to high nuclear FokI levels and correspondingly greater burnout.
Low (gray) and zero (red) tamoxifen as well as zero tamoxifen/Shield1 (green) show less
nuclear FokI and less burnout (n ≥ 3 experiments). (D, E) Inhibition of ATM kinase, which
phosphorylates H2AX to make γH2AX, decreases as expected the small mCherry-negative
focus numbers per cell, but it does not decrease FokI focus numbers. Burnout is thus limited
by nuclease induction rather than by repair. Constricted migration through 3 µm transwells
leads to ∼40% more cells with FokI foci on the bottom than on top (n > 3 experiments),
which suggests that mobile protein loss during migration impedes targeted FokI activity,
and so delays burnout. (F) Compared to the non-treated cells, activation of FokI expression
by 1 µM tamoxifen and 1 µM Shield1 does not impede migration, as shown by the number
of migrated cells at the bottom of the transwell (≥ 3 transwells for each group, n ≥ 3
experiments). (G) A FokI focus drawn into a 3 µm pipette loses ∼30% (n ≥ 6 cells) of its
initial intensity within minutes, with suitable correction for constant photobleaching.

with mCherry-positive foci decreases over 24 hours even as the nuclease remains
abundant within the nucleus (Fig. 5.5A-5.5C; Fig. D.4). Reducing the tamoxifen
concentration from high to low (0.1 µM) to zero slows this decay by simply reducing
the amount of FokI that translocates into the nucleus (Fig. 5.5C). Re-activation
with high tamoxifen after 24 hours does not fully recover the FokI foci-positive
population, indicating that the nuclease causes irreversible cleavage or “burnout”
of the locus. Following re-activation, the initially zero- and low-tamoxifen groups
consistently exhibit a higher percent of FokI foci-positive cells than the chronically
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high-tamoxifen group (Fig. 5.5B). Thus, transient reduction in the amount of nuclear
FokI, followed by restoration of high nuclear FokI levels, results in less burnout than
does a sustained high level of the nuclease.
Inhibition of the DNA damage response using an inhibitor of ATM kinase (Hickson
et al. 2004) significantly decreases the number of γH2AX foci—which is expected since
ATM phosphorylation of H2AX, among many targets, generates γH2AX (Shanbhag
et al. 2010)—but the inhibition has zero effect on the number of cells with mCherry-FokI
foci (Fig. 5.5D). Although segregation of repair factors (Fig. 5.1) could conceivably
lead to differences in percent foci-positive cells among migrated and unmigrated
populations, burnout of the engineered locus is clearly limited by nuclease activity
rather than DNA repair. When induced cells are placed on top of a transwell membrane,
constricted migration to the bottom delays burnout of the locus, with almost 50%
more mCherry-positive FokI nuclease foci than on top (Fig. 5.5E). The first possible
explanation that we considered was that damage impedes migration, but nuclease
induction has no effect on the percent of cells that migrate (Fig. 5.5E). However, FokI
does segregate in constrictions (Fig. 5.4D), draining the nucleoplasmic pool available
for exchange with FokI foci (Fig. 5.4C). Indeed, the intensity of a FokI focus decreases
by ∼30% (n ≥ 6 cells) within minutes inside a 3 µm constriction (Fig. 5.5F), which
coincides with the exchange rate shown by the FRAP experiments (Fig. 5.4C). We
considered the possibility that compacted chromatin in the constriction at the specially
engineered locus would accumulate histones. However, histone-H2B remains nearly
unperturbed by the FokI locus and nearly constant in intensity (Fig. D.5, 5.2B-iii)
even though small changes with this histone will be difficult to resolve because it
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binds adjacent unaffected chromosomes which contribute a high background. We have
demonstrated in two dimensions that even a temporary decrease in nucleoplasmic FokI
can delay burnout considerably (Fig. 5.5B, 5.5C). Segregation and mis-localization of
mobile nuclear factors away from chromatin could therefore explain how constricted
migration inhibits highly targeted nuclease activity.

5.3

Discussion

Migration of immune cells through narrow channels with square cross sections has
been seen to constrict the DNA in the nucleus (Thiam et al. 2016), but quantitation
of compaction suggesting a steric limit has not been reported. Our study of cancer
cells is motivated by invasive processes such as metastasis. A first, simple model for
squeeze-out of mobile nuclear factors explains the segregation data well and provides a
mechanistic basis for our hypothesis that severe constriction can arrest nuclease activity.
Chromatin has already been estimated from mobility measurements to occupy f0 ∼
65% of the nuclear volume of cells in static culture (Bancaud et al. 2009), so that the
free volume for diffusion of mobile factors is (1 - f0 ) ∼ 35%. Our data show that a 3-4
µm constriction increases the local density of chromatin by a factor of ∼1.3 (Fig. 5.1B,
5.2B). Hence, inside the pore, fconstricted ∼ 84%, which causes the free volume there
to decrease to (1 - fconstricted ) ∼ 16%. It follows that mobile factors should decline in
the constriction to (1 - fconstricted ) / (1 - f0 ) ∼ 45% of their original abundance, which
is in reasonable agreement with pore and pipette measurements (Fig. 5.1B, 5.2C).
A more complete calculation uses the full range of pore size data (Fig. 5.2C) to
ultimately predict how much of the reduction in burnout of the locus in chromosome 1
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Figure 5.6: (Previous page.) (A) Schematic illustrates chromatin compaction and key
model parameters. In the model, the cell (shown here in side view) is treated as a cylinder
with a cylindrical nucleus of radius Rn and length Ln . The nucleus consists of a solid
chromatin mesh (blue) intermixed with a fluid of mobile nuclear proteins (green). When the
nucleus is constricted, the chromatin squeezes out the protein fluid, and the nuclear radius
and length change by factors of Λr and Λz , respectively. (B) (Compare with Fig. 5.2C.) The
model closely predicts the observed correlations between solid/fluid volume fractions and
pipette diameter. (Upper) Data points show the experimentally measured DNA intensity
ratios for pipettes of different sizes. Blue curve reports the solid volume fraction f predicted
by the theory, which relates to pipette size according to a power law. (Lower) Data points
show measured protein intensity ratios. Green curve is the predicted fluid volume fraction
given by the same power law that determines the solid volume fraction. At the critical
pore size at which the fluid volume fraction vanishes, all of the fluid is squeezed away
from the chromatin. We use this critical pore size to estimate the solid volume fraction
of the undeformed nucleus to be f0 = 0.58. (C) Damage, repair, and mutation rates vary
with the volume fraction f of the solid chromatin mesh, which increases upon constriction.
These curves assume no added nuclease. The mutation rate is the difference between the
damage and repair rates; it gives the number of unrepaired breaks per unit time that lead
to mutations or apoptosis. The arrows indicate the volume fractions corresponding to 8,
5, and 3 µm pores. (D) Higher nuclear FokI concentrations yield a higher percent of FokI
foci-positive cells at 0 hours and, correspondingly, more burnout over 24 hours. Gray points
show experimental data. The percent of FokI foci-positive cells at 0 hours is proportional to
the concentration of nuclease cd /c0 ; the bottom-right data point, representing the highest
cd /c0 , is used to estimate a proportionality constant in the model. The dark red curve
shows the predicted burnout (i.e. change in percent FokI foci-positive cells) between 0 hours
and 24 hours, which increases in magnitude with percent of FokI foci-positive cells at 0
hours—and, by extension, with nuclease concentration. (E) (Compare with Fig. 5.5E.)
Constricted migration delays burnout of the FokI-cleaved locus on chromosome 1. We use
the control bar, which reports the measured % FokI foci-positive cells on top of the transwell
membrane after 24 hours, to estimate the cells’ nuclear FokI concentration. The total height
of the migrated bar amounts to the measured % FokI foci-positive cells on the bottom of
the transwell membrane after 24 hours: the light pink portion gives the control value, the
medium red portion shows the increase in foci-positive cells due to squeeze-out of FokI during
the cells’ 3 hours-long migration through the 3 µm pores, and the dark red portion shows
the increase in foci-positive cells due to mis-localization of FokI following migration-induced
nuclear rupture. The model requires that FokI take ∼1.8 hours after rupture to re-localize
to the nucleus in order to account for the specific observed increase in foci-positive cells
following migration.

(Fig. 5.5E) occurs because of nuclease exclusion from the constriction (Fig.5.4D, 5.4E)
versus rupture into the cytoplasm (Fig. 5.4F). The cell is modeled as a cylinder of
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radius Rc , encasing a cylindrical nucleus of radius Rn and squeezing into a cylindrical
pore of radius Rp < Rn (Fig. 5.6A). When the nucleus is constricted in the radial
direction, the solid mesh pushes the fluid outwards; the change in fluid volume in
the region surrounding the mesh depends on the change in volume of the region
containing the mesh. As the nucleus is deformed, fluid is squeezed out, causing the
solid volume fraction f to increase. From conservation of volume, the constricted
volume is related to the initial volume by
fconstricted =

f0
,
Λz Λ2r

(5.1)

where Λr is the ratio of constricted to original nuclear radius and Λz is the ratio of
constricted to original nuclear length (Fig. 5.6A). Λz is related to Λr by a power
law, Λz = 1/Λαr , 0 ≤ α ≤ 2, which is exact in the small deformation limit. We
fit to the DNA intensity data in figure 5.2 to obtain α = 1.7. Using this power
law, we fit to the protein intensity data to estimate the critical pore diameter of
1.6 µm, at which all the fluid is squeezed out. We use these to estimate the initial
solid volume fraction f0 ≈ 58% (Fig. 5.6B).
Our model incorporates f into a mutation rate density km , which is the difference
between a damage rate density kd and a repair rate density kr and, as such, defines
the number of unrepaired DNA breaks per unit volume per unit time for a given
cell (Fig. 5.6C). The first term, kd , is just the sum of a basal damage rate density
and an induced damage rate density:


kd = κd

cd
f + (1 − f ) ,
c0
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where κd is a rate constant, cd is the concentration of damage factor (i.e. nuclease)
within the nucleus’s mobile protein fluid, and c0 is a constant to be fitted. The
repair term, kr , is derived from a Langmuir adsorption model, an equilibrium model
that considers the adsorption and desorption rates of repair molecules from break
sites. We use this model to predict the fraction of break sites fr that adsorb a repair
molecule during the time interval δτ , which is set by a desorption rate parameter.
The mutation rate density km = kd - kr then becomes
km = κd (1 − fr ),

(5.3)

with kd given by Eq. 5.2. We fit the model parameters by setting cd = 0 and comparing
to apoptosis rates in rigid pore migration experiments without added nuclease (Harada
et al. 2014). Equation 5.3 is strictly a function of the solid volume fraction f and,
by extension, of the nuclear deformation.
When there is no added nuclease (cd = 0), an increase in nuclear deformation—
and, with it, an increase in f —raises the mutation rate, as the squeezed-out repair
molecules become unavailable to fix DNA breaks (Fig. 5.6B). However, in the presence
of added nuclease, deformation causes that nuclease to segregate, and so inhibits
its ability to inflict damage. If there is a large concentration of nuclease, then the
decrease in damage during migration is more significant than the decrease in repair
rate, so migration leads to appreciably less net damage. The relationship between
nuclease concentration and corresponding damage (Fig. 5.6D) shows higher nuclease
concentrations leads to a faster burnout rate, and the curve predicted by the model
closely matches experimental data. The model ultimately predicts that squeeze-out of
107

5. Nuclear constriction segregates mobile nuclear proteins away from chromatin
FokI accounts for more than half of the observed delay in burnout (i.e. increase in
percent of FokI foci-positive cells) following transwell migration; the other half can be
explained by nuclear rupture-induced FokI mis-localization (Fig. 5.5E, 5.6E).
This predictive model provides insight into how an unavoidable physical consequence of constricted migration—namely, the squeeze-out of mobile nuclear proteins
because of chromatin compaction—can have important functional consequences for the
cell. In the functional test described here, squeeze-out inhibits by sequestration the
net activity of a targeted nuclease. Similar segregation could also effectively separate
the cell’s repair factors from DNA damage sites inside constrictions, thereby causing
elevated damage in migrating cells independent of nuclear envelope rupture.

5.4

Materials and methods

Cell culture

U2OS human osteosarcoma cells were cultured in DMEM high

glucose media (Gibco, Life Technologies), supplemented with 10% FBS and 1%
penicillin/streptomycin (Sigma-Aldrich). Approximately 250 lac operator repeats (∼9
kb per repeat) were integrated into the p-end of chromosome 1 of U2OS cells. Induction
medium consisting of 4-hydroxytamoxifen (Sigma) and Shield1 ligand (Clontech) was
used to activate the integrated FokI-lac repressor-mCherry construct and induce DNA
breaks, as described previously (Shanbhag et al. 2010). A separate stable cell line of
U2OS expressing YFP-MS2 was utilized and also described previously (Janicki et al.
2004). Where used, protein overexpression was achieved by 24-hour transfection with
Lipofectamine 2000 (Invitrogen, Life Technologies). Most of the expression plasmids
were donated from various research groups, with the exception of mApple-Fibrillarin
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and H2B-GFP, which were gifts from Michael Davidson (Addgene plasmid #54900)
and Geoff Wahl (Kanda et al. 1998) (Addgene plasmid #11680), respectively. EC4
mouse liver cancer cells and A549 human lung cancer epithelial cells were cultured in
supplemented DMEM high glucose media—with 1% NEAA (Gibco, Life Technologies)—
and supplemented Ham’s F12 media (Gibco, Life Technologies), respectively.
Transwell migration

Cells were plated on top of a Transwell membrane (Corning)

at a density of 4.5 × 105 cells/cm2 . and allowed to migrate to the bottom over
the course of 24 hours.
Immunostaining and imaging

Cells were fixed in 4% formaldehyde (Sigma)

for 15 minutes before undergoing 10-minute permeabilization by 0.25% Triton-X
(Sigma), 30-minute blocking by 5% BSA (Sigma), and overnight incubation in primary
antibodies. The antibodies used include lamin-A/C (Santa Cruz and Cell Signaling),
Lamin-B (Santa Cruz), γH2AX (Millipore), 53BP1 (Abcam) and acetylated histone
H3 (K9+K14+K18+K23+K27 Abcam). The cells were then incubated in secondary
antibodies (ThermoFisher) for 1.5 hours, and their nuclei were stained with 8 µM
Hoechst 33342 (ThermoFisher) for 15 minutes. Finally, the cells were mounted
with Prolong Gold antifade reagent (Invitrogen, Life Technologies). Epifluorescence
imaging was done using an Olympus IX71—with a 40×/0.6 NA objective—and a
digital EMCCD camera (Cascade, Photometrics). Confocal imaging was done on
a Leica TCS SP8 system, equipped with either a 63×/1.4 NA oil-immersion or a
40×/1.2 NA water-immersion objective. ImageJ (Schneider et al. 2012) and MATLAB
were used to quantify the resulting images.
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Micropipette aspiration

In preparation for aspiration, cells were: (1) detached

using 0.05% Trypsin-EDTA (Gibco, Life Technologies); (2) incubated in 0.2 µg/mL
latrunculin-A (Sigma) and 8 µM Hoechst 33342 (ThermoFisher) for 30 minutes
at 37◦ C, as described previously (Pajerowski et al. 2007); and (3) re-suspended in
PBS with 1% BSA and 0.2 µg/mL latrunculin-A. During aspiration, epifluorescence
imaging was done using a Nikon TE300—with a 60×/1.25 NA oil-immersion objective—
and a digital EMCCD camera (Cascade, Photometrics). The resulting images were
quantified in ImageJ (Schneider et al. 2012).
Image analysis

During micropipette aspiration, the portion of the nucleus outside

the pipette extends across a greater depth than does the portion inside. Thus, because
epifluorescence signal is cumulative along the optical axis (z per Fig. 5.1A), there
are more photons collected outside the pipette than inside, which artificially deflates
the inside-to-outside intensity ratio. To correct for this effect, one can introduce a
geometric factor α. The chromatin’s solid volume fraction f can then be written
in terms of α as f = ((1 − 1/αx)/(x − 1)) Iratio−DN A , where Iratio−DN A is the DNA
intensity ratio and x is its maximum value. Similarly, the fluid volume fraction ρ
can be expressed as ρ = ((1 − 1/αx)/y) Iratio−protein , where Iratio−protein is the protein
intensity ratio with maximum value y. Plugging these expressions into the relation
ρ = 1 − f , it is straightforward to solve for Iratio−protein as a function of Iratio−DN A .
DNA and protein intensity ratios prove to be negatively linearly correlated irrespective
of the exact value of the geometric factor α.
Comet assay

Alkaline comet assays were performed according to the manufacturer-

issued protocol (Cell Biolabs). Image processing to determine the centroid of main
110

5. Nuclear constriction segregates mobile nuclear proteins away from chromatin
nuclear body and its comet tail was done in MATLAB (MathWorks). Intensity
thresholding was used to locate the comet area, whereas distribution of the intensity
derivatives was used locate the main nuclear body area. The centroids were calculated
from the area locations.
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Supplemental materials for Chapter 2
A.1

Cancer types and the microelasticities of the
healthy tissues in which they arise

Cancer type
Pilocytic astrocytoma
Acute myeloid leukemia (AML)
Acute lymphoblastic leukemia (ALL)
Chronic lymphocytic leukemia (CLL)
Medulloblastoma (MB)
Carcinoid
Neuroblastoma
Thyroid
Glioma low grade
Glioblastoma
Breast
Lymphoma B cell
Multiple myeloma
Kidney chromophobe
Prostate
Ovary
Kidney papillary cell
Kidney clear cell
Pancreas
Liver

Normal tissue stiffness (kPa)
0.4 (Swift et al. 2013)
0.3 (Shin et al. 2014)
0.3 (Shin et al. 2014)
0.3 (Shin et al. 2014)
0.4 (Swift et al. 2013)
0.4 (Swift et al. 2013)
0.4 (Swift et al. 2013)
2.2 (Prabhune et al. 2012)
0.4 (Swift et al. 2013)
0.4 (Swift et al. 2013)
0.4-1.1 (Lopez et al. 2011)
0.3 (Shin et al. 2014)
0.3 (Shin et al. 2014)
2.6 (Swift et al. 2013)
3.0-3.8 (Hoyt et al. 2008; Lekka et al. 2012a)
2.5 (Xu et al. 2012)
2.6 (Swift et al. 2013)
2.6 (Swift et al. 2013)
2.7 (Cross et al. 2011)
1.3 (Swift et al. 2013)
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Endometrium
1.3 (Lekka et al. 2012a)
Head and neck
Uterus
1.3 (Lekka et al. 2012a)
Cervix
1.6 (Guz et al. 2014)
Colorectum
0.9 (Kawano et al. 2015)
Esophagus
4.7 (Fuhrmann et al. 2011)
Lung small cell
5.9 (Swift et al. 2013)
Stomach
1.3 (Lim et al. 2009)
Bladder
3.2 (Lekka et al. 2012b)
Lung adenocarcinoma
5.9 (Swift et al. 2013)
Lung squamous
5.9 (Swift et al. 2013)
Melanoma
3.8-6.4 (Petrie et al. 2012; Swift et al. 2013)
Squamous cell carcinoma
3.8-6.4 (Petrie et al. 2012; Swift et al. 2013)
Basal cell carcinoma
3.8-6.4 (Petrie et al. 2012; Swift et al. 2013)
Childhood cancers
ALL
0.3 (Shin et al. 2014)
MB
0.4 (Swift et al. 2013)
Rhabdomyosarcoma 11.9-25.7 (Mathur et al. 2001; Swift et al. 2013)
Osteosarcoma
34.3 (Swift et al. 2013)
Table A.1: Cancer types and the microelasticities of the healthy tissues in which they

arise
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mained intact (see the supplementary materials).
A linear correlation equal to 0.804 suggests
that 65% (39% to 81%; 95% CI) of the differences
in cancer risk among different tissues can be explained by the total number of stem cell divisions
in those tissues. Thus, the stochastic effects of
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A

B

C

Figure B.1: Tomasetti and Vogelstein correlated human cancer risk with DNA replication
in all normal tissue stem cells, and the correlation is steeper for the stiffer tissues, which
present stiffer obstacles during migration. (Continued next page.)
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Figure B.1: (Previous page.) (A) Tomasetti and Vogelstein showed that the lifetime
cancer risk R for a given tissue increases with the lifetime number of stem cell divisions D in
that tissue (Tomasetti and Vogelstein 2015). Nowak and Waclaw used a simple mathematical
model to predict that R should be linearly proportional to D in the one-hit (oncogene)
initiation case and to D2 /N in the two-hit (tumor suppressor genes) initiation case. N is the
number of stem cells present in the tissue. However, in each case, the correlation is sub-linear
for reasons yet unknown (Nowak and Waclaw 2017). Plotted data were obtained from
Tomasetti and Vogelstein (2015), and the classification of cancers as either ‘deterministic’
or ‘replicative’ was adapted from Nowak and Waclaw (2017). (B) Fitting only the stiffest
tissues (red points and line) yields both an improved R2 value and a slope closer to the
expected value of one. These improvements hint at an interaction between tissue stiffness
and mutations in replication. Soft tissues and tissues of intermediate stiffness are fit with a
dark green line. (C) Idealized plot illustrating that cancer risk R increases with stem cell
divisions D, as shown above in A and B, and both increase with tissue stiffness (Klein et al.
2009; Pfeifer et al. 2017).
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Figure S2
For three different cancer cell lines, H2AX foci counts are suppressed in late cell cycle
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Figure B.2: For all three cancer cell lines tested, the number of γH2AX foci per DNA
decreases in late cell cycle, consistent with cell cycle checkpoints for DNA damage. (Continued
next page.)

119

B. Supplemental materials for Chapter 3

Figure B.2: (Previous page.) (A) Across seven experimental conditions (3 µm/8 µm,
top/bottom, 2D low/med/high), the average number of γH2AX foci per total DNA content
was calculated for every phase of the cell cycle (G1, eS, lS, G2, M), and then normalized to
the the average number of γH2AX foci per DNA in G1. These normalized values were then
averaged across all experimental conditions. ‘ND’ = ‘not detected’ (≥60 cells per condition,
n = 2 expts, error bars = SEM). (B) Using fluorescence microscopy of Hoechst-stained cells,
mitotic spindles were counted for each experimental condition (3 µm/8 µm, top/bottom,
2D low/med/high), and % mitotic was calculated. ‘ND’ = ‘not detected’ (≥60 cells per
condition, n = 2 expts, error bars = SEM).
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Figure S3
Averaging across multiple U2OS migration experiments confirms that constriction depletes 4N cells and increases DNA breaks
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Figure B.3: Multiple U2OS migration experiments confirm that constricting pores deplete
the population of 4N cells and cause excess DNA damage. (Continued next page.)

121

B. Supplemental materials for Chapter 3

Figure B.3: (Previous page.) (A) In eight separate U2OS transwell migration experiments,
cells were measured for γH2AX foci number and, based on total DNA content, classified
as 2N or 4N. Plots show average values of % 4N, γH2AX foci, γH2AX foci per total DNA
content in 4N nuclei (relative to γH2AX foci per DNA in 2N nuclei), and cell density.
Asterisk indicates a significant difference in % 4N between 3 µm ‘Bottom’ and ‘Top’ cells
(p = 0.02) (≥60 cells per condition, n = 8 expts, error bars = SEM). (B) (i) For each
experimental condition (i.e. 3 µm/8 µm, top/bottom, 2D low/med/high), the average
number of γH2AX foci was calculated for every phase of the cell cycle (G1, eS, lS, G2, M),
and then normalized to the the average number of γH2AX foci in G1. These normalized
values were then averaged across all experimental conditions (≥60 cells per condition, n
= 2 expts, error bars = SEM). The same analysis was performed for γH2AX foci in U251
and A549 cells (Fig. 3.5A) as well as for BRCA1 and 53BP1 foci in U2OS cells. (ii) As
described in Fig. 3.5A, the “predicted” number of BRCA1 and 53BP1 foci was computed for
3 µm and 8 µm top and bottom. Then, the measured (bottom/top) foci ratio was plotted
against the predicted foci ratio. Unlike γH2AX foci, excess BRCA1 foci after constriction
can be explained as a consequence of perturbations to the cell cycle distribution. Meanwhile,
constricted migration does not cause an increase in 53BP1 foci in U2OS cells.
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Figure S4
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Figure B.4: Partial knockdown of the topoisomerase TOP2A does not eliminate excess
DNA damage due to constricted migration. (Continued next page.)
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Figure B.4: (Previous page.) (A) (i) siRNA was used to partially knock down the
topoisomerase TOP2A. Knockdown efficiency was determined by immunofluorescence
microscopy. Asterisk indicates that TOP2A intensity is significantly lower in siTOP2A cells
than in NT (p < 1×10−9 ) or siCtrl (p < 1×10−14 ) cells; TOP2A intensity is slightly but
significantly (p = 0.04) elevated in siCtrl cells compared to NT (≥120 cells per condition,
error bars = SEM). (ii) Following 72-hour transfection with siRNA targeting TOP2A, U2OS
cells were migrated through 3 µm pores. (iii) If TOP2A were responsible for the excess
DNA damage observed after 3 µm pore migration, then siTOP2A cells would be expected
to show a smaller increase in γH2AX foci after migration than their wild-type (non-treated
or siCtrl) counterparts. However, partial depletion of TOP2A does not strongly affect the
excess DNA damage, indicating that the damage is not caused by topoisomerase activity.
The asterisk indicates that siTOP2A cells on ‘Top’ show a small but significant (p < 0.05)
decrease in γH2AX foci compared to NT or siCtrl cells on ‘Top’, which is sensible given
that topoisomerase is a source of DNA breaks. There is no significant difference in γH2AX
foci among any of the ‘Bottom’ conditions (≥135 cells per condition, n = 2 expts, error bars
= SEM). (B) (i) U2OS cells were migrated through 3 µm pores in the presence of the drug
etoposide, which induces DNA damage during S phase. (ii) Etoposide does not affect the
rate at which cells migrate through small pores (Irianto et al. 2017), with both 2N and 4N
cells migrating (iii) (≥75 cells per condition, error bars = SEM).
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Figure S5
Treatment with PD, a CDK4/6 inhibitor, suppresses DNA synthesis and mitosis, effectively ‘freezing’ cells in G1 or G2
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Figure B.5: Treatment with PD, a CDK4/6 inhibitor, suppresses DNA synthesis and
mitosis, effectively ‘freezing’ cells in G1 or G2. (A) After 72-hour treatment with 10 µM PD,
U2OS cells show a reduction in S phase, as indicated by EdU incorporation, and mitosis,
as indicated by Hoechst-stained mitotic spindles. Both small (2N) and large (4N) nuclei
are observed after PD treatment, suggesting that cells are arrested in either G1 or G2 (≥80
cells per condition, n = 3 expts). (B) PD treatment yields a reduced cell density on the top
and bottom of the transwell membrane, as compared to the control condition (Fig. 3.2C)
(≥75 cells per condition, n = 2 expts, error bars = SEM).
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Theoretical model for curvature-driven dilational flow of lamin-B

In contrast to lamin-A monomers, lamin-B monomers include a farnesyl group that
is hydrophobic and tethers the monomers to the hydrophobic part of the inner lipid
membrane of the nuclear envelope (Hennekes and Nigg 1994). Due to these connections,
lamin-B filaments follow the contour of the lipid membrane at monomer length scales;
the filaments are forced to bend if distortions are imposed on the nuclear envelope,
which may contribute significantly to the bending rigidity of the entire envelope. We
hypothesize that the lamin-B filaments, although fairly stable, can locally slide across
the bilayer and “flow” at sufficiently long times. This flow can result in a transfer
of lamin-B from high-curvature regions to less curved ones in order to minimize
the overall bending energy of the nuclear envelope. Micropipette aspiration is one
126
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Tissue stiffness

Under controlled pressure, lamin-B dilates per theoretical predictions and a repair factor leaks
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Figure C.1: As reported in Figure 4.1, controlled pressure was applied to A549 cells in
which the genomic LMNB1 gene is tagged with a red fluorescent protein. The cells showed
loss of LMNB1 at the tip of the nucleus, signaled by a decline over time in the tip-tooutside RFP-LMNB1 intensity ratio. Here, a phenomenological theory of the time-dependent
redistribution of lamin-B during constriction predicts how the change in concentration of
lamin-B molecules at the nuclear tip varies with pipette radius Rp . The absolute value
of the RFP-LMNB1 intensity ratio slope (Fig. 4.1A-4.1B) is predicted to decrease with
increasing pipette radius such that |slope| is linear in 1/radius4 . Data points are taken from
Fig. 4.1B and fit according to the predicted scaling from the phenomenological theory (blue
line). Inset is a schematic diagram of the deformed shape of the nucleus during aspiration.
This deformed shape is roughly divided into three regions: (1) a spherical nuclear region of
radius Rn ; (2) a cylindrical region of radius Rp ; and (3) a tip region, which is a spherical
section of radius Rp .

example of an experimental technique that distorts the nucleus. The nucleus, which
is approximately spherical with a uniform lamin-B concentration (measured by the
fluorescence intensity of endogenously RFP-tagged lamin-B) when undeformed, is
deformed to a shape similar to the one depicted in Fig. C.1 (inset) during aspiration.
This deformed shape can be roughly divided into three regions: (1) a nuclear region,
which is a spherical section of radius Rn ; (2) a cylindrical region with radius Rp (the
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radius of the pipette) and length L; and (3) a tip region, which is a spherical section
with radius Rp . The shape of the nuclear envelope must change smoothly between
the regions (to avoid the infinite bending energy associated with cusps); therefore,
the different regions must be connected by relatively small transition regions where
the bending energy may be higher than in the smooth regions that surround them.
The distortions induced by aspiration promote redistribution of lamin-B from the tip
region to the nuclear region through the cylinder and connective transition regions.
In what follows, we use a phenomenological model of the various energies involved to
predict the time-dependent redistribution of lamin-B as a consequence of micropipette
aspiration. High-resolution imaging of the lamina reveals a multi-layered structure,
with each layer having a thickness of ∼3.5 nm and a mesh size that spatially varies
(Turgay et al. 2017). We coarse-grain the lamin B layer and model it as a continuous,
viscoelastic gel layer that is locally isotropic (i.e. the bending energy per unit area
is independent of the bending direction). To account for the inhomogeneity in the
network mesh size (and, hence, in the lamin-B density), we define a local lamin-B
concentration, denoted CB . Linear elasticity predicts the bending energy per unit
area fB of a locally-isotropic gel layer to be fB = MB

1
1 2
+
R1 R2

!

(Landau et al.

1986), where MB is the bending modulus (units of energy) and R1,2 are the two local
radii of curvature. Because we expect the bending modulus to be proportional to
the number of filaments that are being deformed, we relate the bending modulus MB
and CB by the phenomenological equation MB = αCB (α is a molecular length scale
related to the microscopic structure of the lamin-B network).
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We denote the time-dependent lamin-B concentration in the nuclear, cylindrical,
and tip regions of the aspirated nucleus by CB,n , CB,c , and CB,t , respectively. We
assume that the local strain (change in area) due to aspiration is small, and therefore
we take the initial values of the concentrations to be uniform and equal to CB,0 . The
bending energies per unit area of the lamin-B network in the nuclear, cylindrical,
and tip regions are therefore initially fB,n = 4αCB,n /Rn2 , fB,c = αCB,c /Rp2 (in the
cylinder, one of the radii of curvature is infinity), and fB,t = 4αCB,t /Rp2 , respectively.
Over sufficiently long timescales, the lamin-B monomers may associate and dissociate
from the filament structure. In the cylindrical region, which has two different radii
of curvature, such association/dissociation may cause local rearrangements of the
lamin-B network such that the network’s local isotropy breaks down; the driving force
for a non-isotropic rearrangement is the reorientation of the lamin-B filaments along
the axis of the cylinder in a way that reduces the bending energy. However, FRAP
experiments show that the turnover time of lamin-B is on the order of a day (Daigle
et al. 2001), while the experiment duration is on the order of an hour, meaning that
the effect of lamin-B association/dissociation can be disregarded.
In equilibrium, the distribution of the lamin-B filaments is set by the competition
between the bending energy in each region and the entropy, as expressed by the
factor of kB T in the Boltzmann factor. Thus, the lamin-B concentration in each
region is proportional to the Boltzmann factor: CB ∼ e−βEB , where EB = fB α2 is
the total bending energy of a filament and β = 1/(kB T ). The dynamical process that
leads to the equilibrium configuration may be 2D flow of lamin filaments from the
129

C. Supplemental materials for Chapter 4
tip to the nuclear region, or it may be detachment of lamin-B monomers from the
network and bilayer, followed by 3D diffusion and repolymerization and attachment in
another region. FRAP studies indicate that the turnover timescale of lamin-B protein
is on the order of a day (Daigle et al. 2001), so we assume that in the case of an
hours-long micropipette aspiration experiment, the mechanism that governs lamin-B
redistribution is 2D flow, and not lamin-B degradation or production.
We now calculate the flow rate of lamin-B using a phenomenological master
equation for the exchange of lamin-B between the nucleus, cylinder, and tip regions.
The transition zones that connect these regions must be crossed by the flowing
filaments, which have higher bending energies in the transition zones than in the
regions around them. The transition zones thus provide kinetic energy barriers for
the lamin-B flow, which thermodynamically goes “downhill” from the high-bending
energy tip region to the low-bending energy nuclear region. We denote the bending
∗
energy of a filament in the cylinder-tip and cylinder-nuclear connection zone by Ect
∗
and Ecn
, respectively. The rate equations for the lamin-B flow can thus be written as:


dCB,t
D 
∗
∗
=
CB,c e−β(Ect −EB,c ) − CB,t e−β(Ect −EB,t )
dt
Ac

(C.1)

dCB,c
D 
∗
∗
=
CB,n e−β(Ecn −EB,n ) + CB,t e−β(Ect −EB,t )
dt
Ac

∗
∗
− CB,c e−β(Ect −EB,c ) − CB,c e−β(Ecn −EB,c )

(C.2)


dCB,n
D 
∗
∗
=
CB,c e−β(Ecn −EB,c ) − CB,n e−β(Ecn −EB,n ) ,
dt
An

(C.3)
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where D is an effective diffusion constant that mainly depends on the friction between
the lamin-B monomers and the lipid bilayer, and the As are the areas of the different
regions. We note that in the specific geometry depicted in Fig. ?? (inset), no
intermediate configuration of high bending energy is needed in order to flow from
the tip to the cylinder region. This is a special case that results from the smooth
transition between the two regimes, which naturally excludes “cusped” regions.
To solve this set of equations, we use conservation of lamin-B NB = CB,t At +
CB,n An + CB,c Ac (the amount of lamin-B in the connection zones is negligible due
to the very small dimensions of these zones). Therefore:

D
dCB,t
=
dt
At

NB −β(Ect∗ −Ec ) An
∗
e
−
CB,n e−β(Ect −Ec )
Ac
Ac



At −β(Ect∗ −Ec )
∗ −E )
−β(Ect
t
−
e
+e
CB,t
Ac

D
dCB,n
=
dt
An





(C.4)

An −β(Ecn
NB −β(Ecn
∗ −E )
∗ −E )
∗
c
c
e
−
e
+ e−β(Ecn −En ) CB,n
Ac
Ac

At
∗
CB,t e−β(Ecn −Ec ) .
−
Ac




(C.5)

This is a set of two linear ordinary differential equations with constant coefficients
and, therefore, is analytically solvable. However, we are interested only in the early
time (relative to the timescale in which the system undergoes major reorganization to
reach steady state, which can be estimated as ∼1 day according to FRAP studies)
solution in which the dynamics are linear. For timescales, such as the ∼hour-long
aspiration experiment, that are much smaller than the FRAP timescale (>1 day),
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the concentrations of the lamin-B can be replaced with the initial concentration
CB,0 (together with NB = (An + Ac + At )CB,0 ). This substitution results in the
approximate early-time solution for CB,t and CB,n :


Dt
∗
∗
CB,0 e−β(Ect −Ec ) − e−β(Ect −Et )
At

(C.6)



Dt
∗
∗
CB,0 e−β(Ecn −Ec ) − e−β(Ecn −En ) .
An

(C.7)

CB,t = CB,0 +
CB,n = CB,0 +

These results are consistent with linear response theory: If the bending energy gradients
are weak compared with the thermal energy, the exponents can be expanded to linear
order. Expansion shows that the flow rate of the molecules between the tip and the
cylinder regions is proportional to the energy difference Ec − Et , while the flow rate
from the cylinder region to the nuclear region is proportional to Ec − En .
In order to test these predictions in a way that is robust to photobleaching of the
RFP-lamin-B monomers, we derive an expression for the ratio of CB,t /CB,n , which
can be measured experimentally. To linear order in time, the ratio CB,t /CB,n is:

!
∗
∗


CB,t
De−βEct  βEc
De−βEcn  βEc
βEt
βEn
≈1+
e
−e
−
e
−e
t.
CB,n
At
An

(C.8)

∗
∗


De−βEct  βEc
De−βEcn  βEc
βEt
The two terms in the parenthesis,
e
−e
and
e
− eβEn ,
At
An

account for the flow of lamin-B from the tip to the cylinder region and from the
cylinder to the nuclear region. Since the area of the nuclear region is much greater
than the area of the tip region, the relative increase in lamin-B concentration in the
132

C. Supplemental materials for Chapter 4
nuclear region due to the flow is small. However, the relative decrease in CB,t) due
to the flow into the cylinder can be significant. For that reason, the contribution
to CB,t /CB,n of the flow toward the nuclear region can be neglected compared to
the contribution of the flow away from the tip region. Furthermore, the transition
from the tip region to the nuclear region is smooth; thus, the lamin filaments are
not required to bend into an intermediate form with high bending energy in order to
∗
flow to the cylinder, which means that Ect
≈ Et . The expression for the ratio of the

concentrations in the tip and the nucleus at early times can thus be written as:
3βMB,0 α2
−


Dt 

Rp2
≈1+
1 − e
.

At 


CB,t
CB,n



(C.9)

First-order expansion of the exponent for Rp  α and substitution of At = 2πRp2 lead
to the final form for the ratio of concentrations as a function of time:
CB,t
3βDMB,0 α2
≈1−
t.
CB,n
2πRp4

(C.10)

This form is accurate for early times, when the radius of the pipette Rp  Rn
is much smaller than the radius of the nucleus but still greater than the size of
a lamin-B filament Rp  α.
We therefore suggest that the initial rate of the decreasing ratio of fluorescence
intensities of the lamin-B in the tip and nuclear regions (which is equal to the ratio
of the lamin concentrations in the two regions) scales with Rp−4 . This prediction is
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consistent with the experimental measurement as can be seen in Fig. C.1.

C.2

Supplemental figures
A
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Figure C.2: (A) Transwells are commercially available from Corning in a limited assortment
of pore diameters. To generate intermediate pore sizes, the polycarbonate membranes are
etched for varying times with 2 M NaOH at 60◦ C. Scanning electron microscopy images show
membrane pores. (B-C) Commercially available and custom-etched transwell membranes
were imaged by confocal microscopy, and their pore diameters were measured in ImageJ.
For every membrane, the measured pores are highly uniform in size, based on low standard
deviation (SD), and match expected diameter values (one transwell per condition; n = 100
pores for the 3 µm commercial and 4 and 5 µm etched membranes; for all other membranes,
n = 40 pores; error bars = SD). Histograms show tight pore diameter distributions for the 3
µm commercial and 4 and 5 µm etched membranes.
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Figure C.3: Nuclear rupture frequency correlates more closely with curvature than with
applied tension during constricted migration. (Continued next page.)
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Figure C.3: (Previous page.) (A) After detachment and latrunculin treatment, U2OS cells
overexpressing mCherry-cGAS and lamin-B1-GFP were passively pulled into micropipettes of
diameter Dp ≈ 2, 3, 4, 6, and 8 µm. Each data point represents a single aspirated cell, which
is classified as cGAS-positive (“cGAS+”) if it exhibited nuclear entry of mCherry-cGAS
during aspiration, signifying nuclear envelope rupture. Tension is given by applied pressure
(which varied between cells) times pipette circumference (Rp = pipette radius). (B) Using
the data in A, a critical tension Tcrit was defined for each Dp such that the probability of
nuclear envelope rupture is the same for T < Tcrit and T > Tcrit . For example, for Dp ≈
6 µm, Tcrit = 4.8 kPa ·µm, and Prupture (T < Tcrit ) = Prupture (T > Tcrit ) = 0.33, where
Prupture denotes the rupture probability. Critical pressure and force were determined in the
same way. Referring to Prupture (T < Tcrit ) = Prupture (T > Tcrit ) as the “equi-probability,”
we plot equi-probability as a function of curvature, critical pressure, critical tension, and
critical force for every Dp . Equi-probability yields a better fit (higher R2 ) when plotted
against curvature than against tension.(C) Spider plot summarizes quantification of detached,
latrunculin-treated U2OS cells that either exhibit nuclear envelope rupture (red) or not (blue)
when passively pulled into micropipettes of diameter Dp = 4 µm. Each polar axis represents
a different measurement. ∆L/t at t = 1 sec and at ∆L = 10 µm are reported in Fig. 4.2E-ii;
∆L and α at t = 15 sec are reported in Fig. 4.2E-i; and cGAS and pressure are drawn from
the datasets in Fig. 4.2D and Fig. C.3B, respectively. Explanations of these parameters can
be found in the corresponding figure legends (6 cells total, 3 cells per condition; error bars =
SEM). (D) Probing nuclei in living U2OS cells with high-curvature beads (diameter < 0.1
µm) reveals a strong correlation between applied force (or stress) and probability of nuclear
envelope rupture, as indicated by nuclear entry of mCherry-cGAS. Importantly, because
the probe is of height h ∼ 4 µm (schematic diagram), the depth of AFM indentation is
low compared to the nuclear extension ∆L achieved in micropipettes (7 cells total, ≥2 cells
per bin; error bars = SEM). (E) U2OS cells overexpressing GFP-Nup153 show dilution of
nuclear pore complex proteins at the leading tip of the nucleus when passively pulled into
constricting pipettes (Dp = 2.8 µm) but not larger (Dp = 6.8 µm) pipettes (≥5 cells per
Dp ; scale bar: 5 µm). (F) Based on Fig. 4.2E-i. (i) The slope α/∆L was calculated for
each Dp ; slope increases with curvature. (ii) Large pipettes (6, 8 µm) dilute lamin-B1 (high
α) only for extremely rapid extension of the nucleus. Data at ∆L/t ≈ 0.6 µm/s are from
Fig. 4.2E-i; upper points are cells fully aspirated within t ≈ 3 sec and were not included in
Fig. 4.2E-i. (iii) Fig. 4.2E-i is reproduced here, with the parameter ∆L (i.e. the extension
of the nucleus into the pipette) replaced by the dimensionless parameter , which is ∆L at
t ≈ 15 sec normalized to pipette diameter Dp . The rate 0 is defined as /t.
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Figure C.4: As described in Fig. 4.3, A549 cells with gene-edited RFP-lamin-B were
transfected with lamin-A-GFP, detached and latrunculin-treated, and then aspirated at
various rates into pipettes of diam. Dp ≈ 3.5 µm. A critical strain, required for lamin-A to
flow, is evident at early timepoints in aspiration. Given long times (t ≈ 1 hr), most aspirated
cells show lamin-A and lamin-B dilution at the leading tip of the nucleus regardless of initial
extension ∆L into the pipette (n = 14 cells).
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Figure C.5: Rescue of lamin-A knockdown with overexpression of LMNA-GFP yields a
wide range of lamin-A levels. (A) (i) Representative images of U2OS siLMNA knockdown
(KD) cells that have been transfected with LMNA-GFP, and then fixed and stained with
anti-lamin-A. (ii) A ∼60-fold increase in LMNA-GFP intensity, as measured by fluorescence
microscopy, corresponds to a ∼10-fold increase in overall lamin-A expression based on antilamin-A staining (n = 168 cells). Importantly, the 14 cells used in our siLMNA +LMNA-GFP
study, described in Fig. 4.4, show a 50-100-fold range of LMNA-GFP intensities (Fig. 4.4A),
which implies a ∼10-fold range of overall lamin-A levels. (B) Lamin-A KD causes a ∼10-fold
decrease in lamin-A expression, quantified by immunofluorescence (IF) microscopy (p <
0.05; error bars = SEM). (C) Based on Fig. 4.4D. Fits are to all low-lamin-A cells and all
high-lamin-A cells—and have much lower R2 values than the fits in Fig. 4.4D, which assume
that lamin-A only starts diluting above a critical strain ∆L. (D) Additional images show
chromatin herniation (yellow arrows) and nuclear accumulation of mCherry-cGAS (white
arrows) during micropipette aspiration of low-lamin-A cells.
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D.1

FRAP data for mobile nuclear GFP-tagged
proteins

GFPtagged
protein

Molecular
weight, kDa
(Kozlowski
2016) (+GFP)

RPA3
GFP

14 (41)
27

Estimated
Isoelectric
point,
pI
(Kozlowski 2016)
(+GFP)
4.8 (5.2)
5.4

RPA2
Sirt6
YFP-MS2
RelA
RPA1
KU70

29
35
42
60
68
70

5.4
6.0
5.6
5.3
6.5
6.1

Mre11
KU80
NBS1

81 (108)
82 (109)
85 (112)

5.4 (5.4)
5.4 (5.4)
6.2 (5.9)

dCas9
MDC1

158 (185)
196 (223)

8.2 (7.8)
5.0 (5.1)

BRCA1
53BP1

208 (235)
214 (241)

5.2 (5.2)
4.5 (4.6)

(56)
(62)
(87)
(95)
(97)

Mobile fraction

Recovery
half-time, s

Recovery
time, s

95% (Bosisio et al. 2006;
Zheng et al. 2011)

1

4-7

95% (Bosisio et al. 2006)
95% (Gourdin et al. 2014)
90% (Byrum et al. 2004;
Rodgers et al. 2002)
95% (Boisvert et al. 2005)
90% (Mari et al. 2006)
95% (Lukas et al. 2004;
Tobias et al. 2013)

1
8
6-7

7
30
20

3
1
0.5

30
3
3

95% (Lukas et al. 2004;
Tobias et al. 2013)

2

7

100%
(Bekker-Jensen
et al. 2005)

5

50

(5.5)
(5.7)
(5.4)
(5.8)
(5.8)

Table D.1: FRAP data for diffusible nucleoplasmic GFP-tagged proteins
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D.2

Supplemental figures

Figure S1

GFP-Ku80 also segregates in small 3 µm constrictions

A

3 µm pores
DNA

GFP-Ku80
DNA edge

Top/
outside
XY slice

Pore transit/
inside
XY slice
5 µm

Top to
bottom
XZ slice

outside inside

Nuclear GFP-53BP1 proteins are excluded from the nucleoli

B

DNA

GFP-53BP1

mApple-Fibrillarin

Overlay

nucleoli

20 µm

Figure D.1: GFP-KU80 segregates in 3 µm pores, and GFP-53BP1 is excluded from
nucleoli. (A) Representative images show that GFP-KU80—like GFP-53BP1 and YFPNLS in Fig. 5.1A—segregates away from chromatin in 3 µm pores. (B) U2OS cells were
co-transfected with GFP-53BP1 and mApple-Fibrillarin, which indicates the presence of
nucleoli. This representative image shows exclusion of GFP-53BP1 and Hoechst-stained
DNA from nucleolar regions.
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Figure S2
Acetylated histone H3 follows DNA and other chromatin-bound proteins behaviour in constrictions

B

Acetyl-H3
DNA edge

Top/
outside
XY slice

Pore transit/
inside
XY slice
5 µm

1.5

DNA
acetyl-H3

C
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DNA
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Intensity ratio
(Inside/oustside of pore)

A
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25

0

NT

300 nM
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Figure D.2: Acetylated histone H3 flows like DNA into constrictions. (A, B) Like DNA,
the acetylated histone H3 (acetyl-H3) is enriched within 3 µm pores—and therefore has an
intensity ratio >1 (≥15 cells; n = 2 expts). However, the intensity ratio of acetyl-H3 is
lower than that of DNA, which prompted us to confirm acetyl-H3 antibody specificity. (C)
Indeed, inhibition of histone deacetylase by 300 nM Trichostatin A for 12 hours produced an
increase in acetyl-H3 levels, as shown by immunostaining (≥120 cells per group, *p < 0.05).
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Figure S3

Intesity ratio
(inside/outside of pipette)

Scatter plot of intensity ratio data shows >90% of (DNA measurement

1.0) and (mobile factors

DNA
Over-expressed protein
Highest tertile of protein expression
Middle tertile
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S.E.M.

3.0

1.0)
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Figure D.3: U2OS cells overexpressing various nuclear proteins—including chromatinassociated proteins like histone-H2B and mobile proteins like the DNA repair factor BRCA1—
were detached and treated with latrunculin-A to depolymerize the actin cytoskeleton. Cells
were then passively pulled into a 3 µm-diameter pipette, in which well over 90% of the cells
exhibited segregation of mobile proteins away from chromatin. Each symbol reports the
DNA (blue) or protein (green) intensity ratio for a single cell, with mean intensity ratios
for each group given by horizontal dashes. Even those cells that do not exhibit mobile
protein segregation appear to be within statistical uncertainty (gray region) of doing so.
Chromatin-associated nuclear proteins do not segregate, as expected. Protein expression
quantified by fluorescence intensity (≥4 cells per group; n ≥ 3 expts).
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Figure S4
Nuclear FokI levels are higher with addition of Tamoxifen and seem to accumulate over time

Nuclear FokI intensity (AU)

1200
6 hr
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800
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0

NT
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[Tamox., Shield1]

*
** **
**
** **
Figure D.4: FokI cleavage of the specially engineered chromosome 1 locus is induced
at 0 hours by controlled addition of two small molecules [tamoxifen, Shield1]. Tamoxifen
treatment causes an increase in nuclear FokI levels, which are higher after 24 hours of
treatment versus 6 hours (≥100 cells per group, n ≥ 2 expts, *p < 0.05, **p < 0.01).
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Figure S5
H2B remains in the FokI locus site during aspiration

A
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Figure D.5: Histone-H2B remains in the FokI focus site during aspiration. (A) U2OS cells
overexpressing H2B-GFP were treated with tamoxifen and Shield1 to induce FokI cleavage
of the engineered chromosome 1 locus, and then passively pulled into ∼3 µm-diameter
pipettes. Representative images show H2B-GFP and mCherry-FokI over a period of 20
minutes. Intensity profiles across the FokI focus and the surrounding H2B-GFP indicate
that mCherry-FokI depletes at the focus, but H2B-GFP does not. (B, C) Intensity profiles
for two additional nuclei also indicate depletion of mCherry-FokI—but not H2B-GFP—over
20 minutes of aspiration.
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